{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 115395, "items": [{"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T13:45:50Z", "timestamp": 1575207950018}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CCDT"], "published-print": {"date-parts": [[2013, 5, 1]]}, "DOI": "10.2174/15680096113139990077", "type": "journal-article", "created": {"date-parts": [[2013, 4, 10]], "date-time": "2013-04-10T14:49:05Z", "timestamp": 1365605345000}, "page": "379-399", "source": "Crossref", "is-referenced-by-count": 69, "title": ["DNA Methyltransferase-1 Inhibitors as Epigenetic Therapy for Cancer"], "prefix": "10.2174", "volume": "13", "author": [{"given": "Varinder", "family": "Singh", "sequence": "first", "affiliation": []}, {"given": "Prince", "family": "Sharma", "sequence": "additional", "affiliation": []}, {"given": "Neena", "family": "Capalash", "sequence": "additional", "affiliation": []}], "member": "965", "container-title": ["Current Cancer Drug Targets"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/109882", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2015, 11, 23]], "date-time": "2015-11-23T08:31:11Z", "timestamp": 1448267471000}, "score": 47.265053, "issued": {"date-parts": [[2013, 5, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2013, 5, 1]]}, "issue": "4"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/15680096113139990077", "ISSN": ["1568-0096"], "issn-type": [{"value": "1568-0096", "type": "print"}], "subject": ["Cancer Research", "Pharmacology", "Drug Discovery"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T04:52:38Z", "timestamp": 1574484758764}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2011, 4, 15]]}, "DOI": "10.1158/1538-7445.am2011-3016", "type": "proceedings-article", "created": {"date-parts": [[2012, 6, 27]], "date-time": "2012-06-27T21:18:07Z", "timestamp": 1340831887000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract 3016: Roles of histone deacetylase inhibitors in the regulation of DNA methyltransferase 1"], "prefix": "10.1158", "author": [{"given": "Asami", "family": "Takashima", "sequence": "first", "affiliation": []}, {"given": "Douglas V.", "family": "Faller", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 13]]}, "event": {"name": "Proceedings: AACR 102nd Annual Meeting 2011\u2010\u2010 Apr 2\u20106, 2011; Orlando, FL"}, "container-title": ["Cellular and Molecular Biology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2011-3016", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T21:49:54Z", "timestamp": 1558216194000}, "score": 26.028, "issued": {"date-parts": [[2011, 4, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2011-3016"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2011-3016"}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T13:10:49Z", "timestamp": 1574773849418}, "reference-count": 47, "publisher": "Medknow", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Indian J Cancer"], "published-print": {"date-parts": [[2015]]}, "DOI": "10.4103/0019-509x.178403", "type": "journal-article", "created": {"date-parts": [[2016, 3, 9]], "date-time": "2016-03-09T12:24:22Z", "timestamp": 1457526262000}, "page": "568", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Therapy and progression \u2013 induced O6-methylguanine-DNA methyltransferase and mismatch repair alterations in recurrent glioblastoma multiforme"], "prefix": "10.4103", "volume": "52", "author": [{"given": "C", "family": "Sarkar", "sequence": "first", "affiliation": []}, {"given": "S", "family": "Agarwal", "sequence": "additional", "affiliation": []}, {"given": "V", "family": "Suri", "sequence": "additional", "affiliation": []}, {"given": "MC", "family": "Sharma", "sequence": "additional", "affiliation": []}], "member": "2581", "container-title": ["Indian Journal of Cancer"], "language": "en", "deposited": {"date-parts": [[2016, 3, 9]], "date-time": "2016-03-09T12:32:02Z", "timestamp": 1457526722000}, "score": 25.618431, "issued": {"date-parts": [[2015]]}, "references-count": 47, "journal-issue": {"published-print": {"date-parts": [[2015]]}, "issue": "4"}, "alternative-id": ["178403"], "URL": "http://dx.doi.org/10.4103/0019-509x.178403", "ISSN": ["0019-509X"], "issn-type": [{"value": "0019-509X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T18:24:44Z", "timestamp": 1574792684094}, "publisher-location": "Cham", "reference-count": 247, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319249490", "type": "print"}, {"value": "9783319249513", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 1, 1]], "date-time": "2016-01-01T00:00:00Z", "timestamp": 1451606400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2016]]}, "DOI": "10.1007/978-3-319-24951-3_2", "type": "book-chapter", "created": {"date-parts": [[2016, 5, 4]], "date-time": "2016-05-04T09:26:02Z", "timestamp": 1462353962000}, "page": "27-63", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Epigenetic Changes and Potential Targets in Pancreatic Cancer"], "prefix": "10.1007", "author": [{"given": "Rajesh", "family": "Singh", "sequence": "first", "affiliation": []}, {"given": "James W.", "family": "Lillard", "sequence": "additional", "affiliation": []}, {"given": "Shailesh", "family": "Singh", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 5, 5]]}, "reference": [{"issue": "1", "key": "2_CR1", "doi-asserted-by": "publisher", "first-page": "5", "DOI": "10.3322/caac.21254", "volume": "65", "author": "RL Siegel", "year": "2015", "unstructured": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5\u201329. doi:\n                10.3322/caac.21254\n                \n              .", "journal-title": "CA Cancer J Clin"}, {"issue": "4", "key": "2_CR2", "doi-asserted-by": "publisher", "first-page": "212", "DOI": "10.3322/caac.20121", "volume": "61", "author": "R Siegel", "year": "2011", "unstructured": "Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212\u201336. doi:\n                10.3322/caac.20121\n                \n              .", "journal-title": "CA Cancer J Clin"}, {"issue": "10", "key": "2_CR3", "doi-asserted-by": "publisher", "first-page": "726", "DOI": "10.1038/nrc3130", "volume": "11", "author": "SB Baylin", "year": "2011", "unstructured": "Baylin SB, Jones PA. A decade of exploring the cancer epigenome\u2014biological and translational implications. Nat Rev Cancer. 2011;11(10):726\u201334. doi:\n                10.1038/nrc3130\n                \n              .", "journal-title": "Nat Rev Cancer"}, {"issue": "4", "key": "2_CR4", "doi-asserted-by": "publisher", "first-page": "683", "DOI": "10.1016/j.cell.2007.01.029", "volume": "128", "author": "PA Jones", "year": "2007", "unstructured": "Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128(4):683\u201392. doi:\n                10.1016/j.cell.2007.01.029\n                \n              .", "journal-title": "Cell"}, {"issue": "5", "key": "2_CR5", "doi-asserted-by": "publisher", "DOI": "10.1371/journal.pmed.0050114", "volume": "5", "author": "TA Chan", "year": "2008", "unstructured": "Chan TA, Glockner S, Yi JM, Chen W, Van Neste L, Cope L, Herman JG, Velculescu V, Schuebel KE, Ahuja N, Baylin SB. Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. PLoS Med. 2008;5(5), e114. doi:\n                10.1371/journal.pmed.0050114\n                \n              .", "journal-title": "PLoS Med"}, {"issue": "9", "key": "2_CR6", "doi-asserted-by": "publisher", "first-page": "1709", "DOI": "10.1371/journal.pgen.0030157", "volume": "3", "author": "KE Schuebel", "year": "2007", "unstructured": "Schuebel KE, Chen W, Cope L, Glockner SC, Suzuki H, Yi JM, Chan TA, Van Neste L, Van Criekinge W, van den Bosch S, van Engeland M, Ting AH, Jair K, Yu W, Toyota M, Imai K, Ahuja N, Herman JG, Baylin SB. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet. 2007;3(9):1709\u201323. doi:\n                10.1371/journal.pgen.0030157\n                \n              .", "journal-title": "PLoS Genet"}, {"issue": "7153", "key": "2_CR7", "doi-asserted-by": "publisher", "first-page": "553", "DOI": "10.1038/nature06008", "volume": "448", "author": "TS Mikkelsen", "year": "2007", "unstructured": "Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim TK, Koche RP, Lee W, Mendenhall E, O\u2019Donovan A, Presser A, Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C, Lander ES, Bernstein BE. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature. 2007;448(7153):553\u201360. doi:\n                10.1038/nature06008\n                \n              .", "journal-title": "Nature"}, {"issue": "1", "key": "2_CR8", "doi-asserted-by": "publisher", "first-page": "80", "DOI": "10.1016/j.stem.2008.11.011", "volume": "4", "author": "K Cui", "year": "2009", "unstructured": "Cui K, Zang C, Roh TY, Schones DE, Childs RW, Peng W, Zhao K. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell. 2009;4(1):80\u201393. doi:\n                10.1016/j.stem.2008.11.011\n                \n              .", "journal-title": "Cell Stem Cell"}, {"issue": "7271", "key": "2_CR9", "doi-asserted-by": "publisher", "first-page": "315", "DOI": "10.1038/nature08514", "volume": "462", "author": "R Lister", "year": "2009", "unstructured": "Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, Edsall L, Antosiewicz-Bourget J, Stewart R, Ruotti V, Millar AH, Thomson JA, Ren B, Ecker JR. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009;462(7271):315\u201322. doi:\n                10.1038/nature08514\n                \n              .", "journal-title": "Nature"}, {"issue": "8", "key": "2_CR10", "doi-asserted-by": "publisher", "first-page": "789", "DOI": "10.1038/nm1087", "volume": "10", "author": "B Vogelstein", "year": "2004", "unstructured": "Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004;10(8):789\u201399. doi:\n                10.1038/nm1087\n                \n              .", "journal-title": "Nat Med"}, {"issue": "2", "key": "2_CR11", "doi-asserted-by": "publisher", "first-page": "111", "DOI": "10.2353/jmoldx.2008.070115", "volume": "10", "author": "G Feldmann", "year": "2008", "unstructured": "Feldmann G, Maitra A. Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts. J Mol Diagn. 2008;10(2):111\u201322. doi:\n                10.2353/jmoldx.2008.070115\n                \n              .", "journal-title": "J Mol Diagn"}, {"key": "2_CR12", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1146/annurev.pathmechdis.3.121806.154305", "volume": "3", "author": "A Maitra", "year": "2008", "unstructured": "Maitra A, Hruban RH. Pancreatic cancer. Annu Rev Pathol. 2008;3:157\u201388. doi:\n                10.1146/annurev.pathmechdis.3.121806.154305\n                \n              .", "journal-title": "Annu Rev Pathol"}, {"issue": "1", "key": "2_CR13", "first-page": "1", "volume": "18", "author": "C Caldas", "year": "1995", "unstructured": "Caldas C, Kern SE. K-ras mutation and pancreatic adenocarcinoma. Int J Pancreatol. 1995;18(1):1\u20136.", "journal-title": "Int J Pancreatol"}, {"issue": "5897", "key": "2_CR14", "doi-asserted-by": "publisher", "first-page": "1801", "DOI": "10.1126/science.1164368", "volume": "321", "author": "S Jones", "year": "2008", "unstructured": "Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008;321(5897):1801\u20136. doi:\n                10.1126/science.1164368\n                \n              .", "journal-title": "Science"}, {"issue": "11", "key": "2_CR15", "first-page": "2140", "volume": "57", "author": "CA Moskaluk", "year": "1997", "unstructured": "Moskaluk CA, Hruban RH, Kern SE. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res. 1997;57(11):2140\u20133.", "journal-title": "Cancer Res"}, {"issue": "6", "key": "2_CR16", "doi-asserted-by": "publisher", "first-page": "1821", "DOI": "10.1016/S0002-9440(10)65054-7", "volume": "156", "author": "RH Hruban", "year": "2000", "unstructured": "Hruban RH, Wilentz RE, Kern SE. Genetic progression in the pancreatic ducts. Am J Pathol. 2000;156(6):1821\u20135. doi:\n                10.1016/s0002-9440(10)65054-7\n                \n              .", "journal-title": "Am J Pathol"}, {"issue": "1", "key": "2_CR17", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.1158/0008-5472.CAN-05-2168", "volume": "66", "author": "RH Hruban", "year": "2006", "unstructured": "Hruban RH, Adsay NV, Albores-Saavedra J, Anver MR, Biankin AV, Boivin GP, Furth EE, Furukawa T, Klein A, Klimstra DS, Kloppel G, Lauwers GY, Longnecker DS, Luttges J, Maitra A, Offerhaus GJ, Perez-Gallego L, Redston M, Tuveson DA. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res. 2006;66(1):95\u2013106. doi:\n                10.1158/0008-5472.can-05-2168\n                \n              .", "journal-title": "Cancer Res"}, {"issue": "24", "key": "2_CR18", "doi-asserted-by": "publisher", "first-page": "3112", "DOI": "10.1101/gad.1158703", "volume": "17", "author": "AJ Aguirre", "year": "2003", "unstructured": "Aguirre AJ, Bardeesy N, Sinha M, Lopez L, Tuveson DA, Horner J, Redston MS, DePinho RA. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 2003;17(24):3112\u201326. doi:\n                10.1101/gad.1158703\n                \n              .", "journal-title": "Genes Dev"}, {"issue": "5", "key": "2_CR19", "doi-asserted-by": "publisher", "first-page": "469", "DOI": "10.1016/j.ccr.2005.04.023", "volume": "7", "author": "SR Hingorani", "year": "2005", "unstructured": "Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, Hruban RH, Rustgi AK, Chang S, Tuveson DA. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell. 2005;7(5):469\u201383. doi:\n                10.1016/j.ccr.2005.04.023\n                \n              .", "journal-title": "Cancer Cell"}, {"issue": "15", "key": "2_CR20", "doi-asserted-by": "publisher", "first-page": "5947", "DOI": "10.1073/pnas.0601273103", "volume": "103", "author": "N Bardeesy", "year": "2006", "unstructured": "Bardeesy N, Aguirre AJ, Chu GC, Cheng KH, Lopez LV, Hezel AF, Feng B, Brennan C, Weissleder R, Mahmood U, Hanahan D, Redston MS, Chin L, Depinho RA. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc Natl Acad Sci U S A. 2006;103(15):5947\u201352. doi:\n                10.1073/pnas.0601273103\n                \n              .", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "48", "key": "2_CR21", "doi-asserted-by": "publisher", "first-page": "18913", "DOI": "10.1073/pnas.0810097105", "volume": "105", "author": "N Habbe", "year": "2008", "unstructured": "Habbe N, Shi G, Meguid RA, Fendrich V, Esni F, Chen H, Feldmann G, Stoffers DA, Konieczny SF, Leach SD, Maitra A. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc Natl Acad Sci U S A. 2008;105(48):18913\u20138. doi:\n                10.1073/pnas.0810097105\n                \n              .", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "6", "key": "2_CR22", "doi-asserted-by": "publisher", "first-page": "437", "DOI": "10.1016/S1535-6108(03)00309-X", "volume": "4", "author": "SR Hingorani", "year": "2003", "unstructured": "Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, Ross S, Conrads TP, Veenstra TD, Hitt BA, Kawaguchi Y, Johann D, Liotta LA, Crawford HC, Putt ME, Jacks T, Wright CV, Hruban RH, Lowy AM, Tuveson DA. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 2003;4(6):437\u201350.", "journal-title": "Cancer Cell"}, {"issue": "38", "key": "2_CR23", "doi-asserted-by": "publisher", "first-page": "5923", "DOI": "10.1038/sj.onc.1205643", "volume": "21", "author": "T Hirano", "year": "2002", "unstructured": "Hirano T, Shino Y, Saito T, Komoda F, Okutomi Y, Takeda A, Ishihara T, Yamaguchi T, Saisho H, Shirasawa H. Dominant negative MEKK1 inhibits survival of pancreatic cancer cells. Oncogene. 2002;21(38):5923\u20138. doi:\n                10.1038/sj.onc.1205643\n                \n              .", "journal-title": "Oncogene"}, {"issue": "24", "key": "2_CR24", "doi-asserted-by": "publisher", "first-page": "9067", "DOI": "10.1073/pnas.0402932101", "volume": "101", "author": "AJ Aguirre", "year": "2004", "unstructured": "Aguirre AJ, Brennan C, Bailey G, Sinha R, Feng B, Leo C, Zhang Y, Zhang J, Gans JD, Bardeesy N, Cauwels C, Cordon-Cardo C, Redston MS, DePinho RA, Chin L. High-resolution characterization of the pancreatic adenocarcinoma genome. Proc Natl Acad Sci U S A. 2004;101(24):9067\u201372. doi:\n                10.1073/pnas.0402932101\n                \n              .", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "15", "key": "2_CR25", "first-page": "3126", "volume": "57", "author": "M Schutte", "year": "1997", "unstructured": "Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE, Herman JG. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res. 1997;57(15):3126\u201330.", "journal-title": "Cancer Res"}, {"issue": "20", "key": "2_CR26", "first-page": "4740", "volume": "58", "author": "RE Wilentz", "year": "1998", "unstructured": "Wilentz RE, Geradts J, Maynard R, Offerhaus GJ, Kang M, Goggins M, Yeo CJ, Kern SE, Hruban RH. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res. 1998;58(20):4740\u20134.", "journal-title": "Cancer Res"}, {"issue": "9", "key": "2_CR27", "doi-asserted-by": "publisher", "first-page": "902", "DOI": "10.1097/01.MP.0000086072.56290.FB", "volume": "16", "author": "A Maitra", "year": "2003", "unstructured": "Maitra A, Adsay NV, Argani P, Iacobuzio-Donahue C, De Marzo A, Cameron JL, Yeo CJ, Hruban RH. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol. 2003;16(9):902\u201312. doi:\n                10.1097/01.mp.0000086072.56290.fb\n                \n              .", "journal-title": "Mod Pathol"}, {"issue": "5247", "key": "2_CR28", "doi-asserted-by": "publisher", "first-page": "350", "DOI": "10.1126/science.271.5247.350", "volume": "271", "author": "SA Hahn", "year": "1996", "unstructured": "Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 1996;271(5247):350\u20133.", "journal-title": "Science"}, {"issue": "11", "key": "2_CR29", "first-page": "2527", "volume": "56", "author": "M Schutte", "year": "1996", "unstructured": "Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, Sidransky D, Casero Jr RA, Meltzer PS, Hahn SA, Kern SE. DPC4 gene in various tumor types. Cancer Res. 1996;56(11):2527\u201330.", "journal-title": "Cancer Res"}, {"issue": "2", "key": "2_CR30", "doi-asserted-by": "publisher", "first-page": "127", "DOI": "10.1016/S0959-437X(03)00026-1", "volume": "13", "author": "K Luger", "year": "2003", "unstructured": "Luger K. Structure and dynamic behavior of nucleosomes. Curr Opin Genet Dev. 2003;13(2):127\u201335.", "journal-title": "Curr Opin Genet Dev"}, {"issue": "14", "key": "2_CR31", "doi-asserted-by": "publisher", "first-page": "3121", "DOI": "10.1111/j.1742-4658.2006.05343.x", "volume": "273", "author": "T Jenuwein", "year": "2006", "unstructured": "Jenuwein T. The epigenetic magic of histone lysine methylation. FEBS J. 2006;273(14):3121\u201335. doi:\n                10.1111/j.1742-4658.2006.05343.x\n                \n              .", "journal-title": "FEBS J"}, {"issue": "4", "key": "2_CR32", "doi-asserted-by": "publisher", "first-page": "693", "DOI": "10.1016/j.cell.2007.02.005", "volume": "128", "author": "T Kouzarides", "year": "2007", "unstructured": "Kouzarides T. Chromatin modifications and their function. Cell. 2007;128(4):693\u2013705. doi:\n                10.1016/j.cell.2007.02.005\n                \n              .", "journal-title": "Cell"}, {"key": "2_CR33", "doi-asserted-by": "publisher", "first-page": "229", "DOI": "10.1146/annurev.pathol.3.121806.151442", "volume": "4", "author": "CA Iacobuzio-Donahue", "year": "2009", "unstructured": "Iacobuzio-Donahue CA. Epigenetic changes in cancer. Annu Rev Pathol. 2009;4:229\u201349. doi:\n                10.1146/annurev.pathol.3.121806.151442\n                \n              .", "journal-title": "Annu Rev Pathol"}, {"issue": "suppl_1", "key": "2_CR34", "doi-asserted-by": "publisher", "first-page": "R85", "DOI": "10.1093/hmg/ddi106", "volume": "14", "author": "Richard J. Gibbons", "year": "2005", "unstructured": "Gibbons RJ. Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes. Hum Mol Genet. 2005;14 Spec No 1:R85\u201392. doi:\n                10.1093/hmg/ddi106\n                \n              .", "journal-title": "Human Molecular Genetics"}, {"issue": "9", "key": "2_CR35", "doi-asserted-by": "publisher", "first-page": "363", "DOI": "10.1016/j.molmed.2007.07.003", "volume": "13", "author": "GG Wang", "year": "2007", "unstructured": "Wang GG, Allis CD, Chi P. Chromatin remodeling and cancer, part I: covalent histone modifications. Trends Mol Med. 2007;13(9):363\u201372. doi:\n                10.1016/j.molmed.2007.07.003\n                \n              .", "journal-title": "Trends Mol Med"}, {"issue": "5", "key": "2_CR36", "doi-asserted-by": "publisher", "first-page": "603", "DOI": "10.1016/j.cell.2004.11.009", "volume": "119", "author": "SL Sanders", "year": "2004", "unstructured": "Sanders SL, Portoso M, Mata J, Bahler J, Allshire RC, Kouzarides T. Methylation of histone H4 lysine 20 controls recruitment of Crb2 to sites of DNA damage. Cell. 2004;119(5):603\u201314. doi:\n                10.1016/j.cell.2004.11.009\n                \n              .", "journal-title": "Cell"}, {"issue": "4", "key": "2_CR37", "doi-asserted-by": "publisher", "first-page": "307", "DOI": "10.1038/nrm2143", "volume": "8", "author": "RJ Klose", "year": "2007", "unstructured": "Klose RJ, Zhang Y. Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol. 2007;8(4):307\u201318. doi:\n                10.1038/nrm2143\n                \n              .", "journal-title": "Nat Rev Mol Cell Biol"}, {"issue": "4", "key": "2_CR38", "doi-asserted-by": "publisher", "first-page": "665", "DOI": "10.1016/j.molcel.2007.11.010", "volume": "28", "author": "RJ Sims 3rd", "year": "2007", "unstructured": "Sims 3rd RJ, Millhouse S, Chen CF, Lewis BA, Erdjument-Bromage H, Tempst P, Manley JL, Reinberg D. Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol Cell. 2007;28(4):665\u201376. doi:\n                10.1016/j.molcel.2007.11.010\n                \n              .", "journal-title": "Mol Cell"}, {"issue": "5616", "key": "2_CR39", "doi-asserted-by": "publisher", "first-page": "131", "DOI": "10.1126/science.1084274", "volume": "300", "author": "K Plath", "year": "2003", "unstructured": "Plath K, Fang J, Mlynarczyk-Evans SK, Cao R, Worringer KA, Wang H, de la Cruz CC, Otte AP, Panning B, Zhang Y. Role of histone H3 lysine 27 methylation in X inactivation. Science. 2003;300(5616):131\u20135. doi:\n                10.1126/science.1084274\n                \n              .", "journal-title": "Science"}, {"issue": "7015", "key": "2_CR40", "doi-asserted-by": "publisher", "first-page": "353", "DOI": "10.1038/nature03117", "volume": "432", "author": "S Chuikov", "year": "2004", "unstructured": "Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS, McKinney K, Tempst P, Prives C, Gamblin SJ, Barlev NA, Reinberg D. Regulation of p53 activity through lysine methylation. Nature. 2004;432(7015):353\u201360. doi:\n                10.1038/nature03117\n                \n              .", "journal-title": "Nature"}, {"issue": "2", "key": "2_CR41", "doi-asserted-by": "publisher", "first-page": "175", "DOI": "10.1016/S1097-2765(04)00182-0", "volume": "14", "author": "A Kouskouti", "year": "2004", "unstructured": "Kouskouti A, Scheer E, Staub A, Tora L, Talianidis I. Gene-specific modulation of TAF10 function by SET9-mediated methylation. Mol Cell. 2004;14(2):175\u201382.", "journal-title": "Mol Cell"}, {"issue": "19", "key": "2_CR42", "doi-asserted-by": "publisher", "first-page": "6756", "DOI": "10.1128/MCB.00460-07", "volume": "27", "author": "GS Ivanov", "year": "2007", "unstructured": "Ivanov GS, Ivanova T, Kurash J, Ivanov A, Chuikov S, Gizatullin F, Herrera-Medina EM, Rauscher 3rd F, Reinberg D, Barlev NA. Methylation-acetylation interplay activates p53 in response to DNA damage. Mol Cell Biol. 2007;27(19):6756\u201369. doi:\n                10.1128/mcb.00460-07\n                \n              .", "journal-title": "Mol Cell Biol"}, {"issue": "4", "key": "2_CR43", "doi-asserted-by": "publisher", "first-page": "391", "DOI": "10.1038/ng1531", "volume": "37", "author": "MF Fraga", "year": "2005", "unstructured": "Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S, Petrie K, Iyer NG, Perez-Rosado A, Calvo E, Lopez JA, Cano A, Calasanz MJ, Colomer D, Piris MA, Ahn N, Imhof A, Caldas C, Jenuwein T, Esteller M. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet. 2005;37(4):391\u2013400. doi:\n                10.1038/ng1531\n                \n              .", "journal-title": "Nat Genet"}, {"issue": "4", "key": "2_CR44", "doi-asserted-by": "publisher", "first-page": "1264", "DOI": "10.1182/blood.V98.4.1264", "volume": "98", "author": "RJ Jaju", "year": "2001", "unstructured": "Jaju RJ, Fidler C, Haas OA, Strickson AJ, Watkins F, Clark K, Cross NC, Cheng JF, Aplan PD, Kearney L, Boultwood J, Wainscoat JS. A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia. Blood. 2001;98(4):1264\u20137.", "journal-title": "Blood"}, {"issue": "4", "key": "2_CR45", "doi-asserted-by": "publisher", "first-page": "950", "DOI": "10.1046/j.1365-2141.2001.02641.x", "volume": "112", "author": "HP Visser", "year": "2001", "unstructured": "Visser HP, Gunster MJ, Kluin-Nelemans HC, Manders EM, Raaphorst FM, Meijer CJ, Willemze R, Otte AP. The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma. Br J Haematol. 2001;112(4):950\u20138.", "journal-title": "Br J Haematol"}, {"issue": "6907", "key": "2_CR46", "doi-asserted-by": "publisher", "first-page": "624", "DOI": "10.1038/nature01075", "volume": "419", "author": "S Varambally", "year": "2002", "unstructured": "Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan AM. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 2002;419(6907):624\u20139. doi:\n                10.1038/nature01075\n                \n              .", "journal-title": "Nature"}, {"issue": "20", "key": "2_CR47", "doi-asserted-by": "publisher", "first-page": "5323", "DOI": "10.1093/emboj/cdg542", "volume": "22", "author": "AP Bracken", "year": "2003", "unstructured": "Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J. 2003;22(20):5323\u201335. doi:\n                10.1093/emboj/cdg542\n                \n              .", "journal-title": "EMBO J"}, {"issue": "1", "key": "2_CR48", "first-page": "113", "volume": "2", "author": "A Kirmizis", "year": "2003", "unstructured": "Kirmizis A, Bartley SM, Farnham PJ. Identification of the polycomb group protein SU(Z)12 as a potential molecular target for human cancer therapy. Mol Cancer Ther. 2003;2(1):113\u201321.", "journal-title": "Mol Cancer Ther"}, {"issue": "20", "key": "2_CR49", "doi-asserted-by": "publisher", "first-page": "11606", "DOI": "10.1073/pnas.1933744100", "volume": "100", "author": "CG Kleer", "year": "2003", "unstructured": "Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, Sabel MS, Livant D, Weiss SJ, Rubin MA, Chinnaiyan AM. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A. 2003;100(20):11606\u201311. doi:\n                10.1073/pnas.1933744100\n                \n              .", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "3", "key": "2_CR50", "doi-asserted-by": "publisher", "first-page": "323", "DOI": "10.1016/S0092-8674(01)00542-6", "volume": "107", "author": "AH Peters", "year": "2001", "unstructured": "Peters AH, O\u2019Carroll D, Scherthan H, Mechtler K, Sauer S, Schofer C, Weipoltshammer K, Pagani M, Lachner M, Kohlmaier A, Opravil S, Doyle M, Sibilia M, Jenuwein T. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell. 2001;107(3):323\u201337.", "journal-title": "Cell"}, {"issue": "1", "key": "2_CR51", "doi-asserted-by": "publisher", "first-page": "94", "DOI": "10.1038/ng1278", "volume": "36", "author": "M Garcia-Cao", "year": "2004", "unstructured": "Garcia-Cao M, O\u2019Sullivan R, Peters AH, Jenuwein T, Blasco MA. Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat Genet. 2004;36(1):94\u20139. doi:\n                10.1038/ng1278\n                \n              .", "journal-title": "Nat Genet"}, {"issue": "10", "key": "2_CR52", "doi-asserted-by": "publisher", "first-page": "4467", "DOI": "10.1073/pnas.92.10.4467", "volume": "92", "author": "IM Buyse", "year": "1995", "unstructured": "Buyse IM, Shao G, Huang S. The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein. Proc Natl Acad Sci U S A. 1995;92(10):4467\u201371.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "6", "key": "2_CR53", "doi-asserted-by": "publisher", "first-page": "2662", "DOI": "10.1073/pnas.040579497", "volume": "97", "author": "RB Chadwick", "year": "2000", "unstructured": "Chadwick RB, Jiang GL, Bennington GA, Yuan B, Johnson CK, Stevens MW, Niemann TH, Peltomaki P, Huang S, de la Chapelle A. Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis. Proc Natl Acad Sci U S A. 2000;97(6):2662\u20137. doi:\n                10.1073/pnas.040579497\n                \n              .", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "44", "key": "2_CR54", "doi-asserted-by": "publisher", "first-page": "6954", "DOI": "10.1038/sj.onc.1206403", "volume": "22", "author": "Y Tokumaru", "year": "2003", "unstructured": "Tokumaru Y, Nomoto S, Jeronimo C, Henrique R, Harden S, Trink B, Sidransky D. Biallelic inactivation of the RIZ1 gene in human gastric cancer. Oncogene. 2003;22(44):6954\u20138. doi:\n                10.1038/sj.onc.1206403\n                \n              .", "journal-title": "Oncogene"}, {"issue": "17", "key": "2_CR55", "doi-asserted-by": "publisher", "first-page": "2250", "DOI": "10.1101/gad.870101", "volume": "15", "author": "G Steele-Perkins", "year": "2001", "unstructured": "Steele-Perkins G, Fang W, Yang XH, Van Gele M, Carling T, Gu J, Buyse IM, Fletcher JA, Liu J, Bronson R, Chadwick RB, de la Chapelle A, Zhang X, Speleman F, Huang S. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev. 2001;15(17):2250\u201362. doi:\n                10.1101/gad.870101\n                \n              .", "journal-title": "Genes Dev"}, {"issue": "22", "key": "2_CR56", "first-page": "7619", "volume": "63", "author": "KC Kim", "year": "2003", "unstructured": "Kim KC, Geng L, Huang S. Inactivation of a histone methyltransferase by mutations in human cancers. Cancer Res. 2003;63(22):7619\u201323.", "journal-title": "Cancer Res"}, {"issue": "7", "key": "2_CR57", "doi-asserted-by": "publisher", "first-page": "941", "DOI": "10.1016/j.cell.2004.12.012", "volume": "119", "author": "Y Shi", "year": "2004", "unstructured": "Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA, Shi Y. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell. 2004;119(7):941\u201353. doi:\n                10.1016/j.cell.2004.12.012\n                \n              .", "journal-title": "Cell"}, {"issue": "21", "key": "2_CR58", "doi-asserted-by": "publisher", "first-page": "6790", "DOI": "10.1158/1078-0432.CCR-08-1013", "volume": "14", "author": "AV Ougolkov", "year": "2008", "unstructured": "Ougolkov AV, Bilim VN, Billadeau DD. Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2. Clin Cancer Res. 2008;14(21):6790\u20136. doi:\n                10.1158/1078-0432.ccr-08-1013\n                \n              .", "journal-title": "Clin Cancer Res"}, {"issue": "2", "key": "2_CR59", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1016/j.gde.2005.01.005", "volume": "15", "author": "R Margueron", "year": "2005", "unstructured": "Margueron R, Trojer P, Reinberg D. The key to development: interpreting the histone code? Curr Opin Genet Dev. 2005;15(2):163\u201376. doi:\n                10.1016/j.gde.2005.01.005\n                \n              .", "journal-title": "Curr Opin Genet Dev"}, {"issue": "11", "key": "2_CR60", "doi-asserted-by": "publisher", "first-page": "829", "DOI": "10.1038/nrg2218", "volume": "8", "author": "Y Shi", "year": "2007", "unstructured": "Shi Y. Histone lysine demethylases: emerging roles in development, physiology and disease. Nat Rev Genet. 2007;8(11):829\u201333. doi:\n                10.1038/nrg2218\n                \n              .", "journal-title": "Nat Rev Genet"}, {"key": "2_CR61", "doi-asserted-by": "publisher", "first-page": "81", "DOI": "10.1146/annurev.biochem.70.1.81", "volume": "70", "author": "SY Roth", "year": "2001", "unstructured": "Roth SY, Denu JM, Allis CD. Histone acetyltransferases. Annu Rev Biochem. 2001;70:81\u2013120. doi:\n                10.1146/annurev.biochem.70.1.81\n                \n              .", "journal-title": "Annu Rev Biochem"}, {"issue": "6711", "key": "2_CR62", "doi-asserted-by": "publisher", "first-page": "594", "DOI": "10.1038/25166", "volume": "396", "author": "J Boyes", "year": "1998", "unstructured": "Boyes J, Byfield P, Nakatani Y, Ogryzko V. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature. 1998;396(6711):594\u20138. doi:\n                10.1038/25166\n                \n              .", "journal-title": "Nature"}, {"issue": "4", "key": "2_CR63", "doi-asserted-by": "publisher", "first-page": "662", "DOI": "10.1093/emboj/19.4.662", "volume": "19", "author": "MA Martinez-Balbas", "year": "2000", "unstructured": "Martinez-Balbas MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T. Regulation of E2F1 activity by acetylation. EMBO J. 2000;19(4):662\u201371. doi:\n                10.1093/emboj/19.4.662\n                \n              .", "journal-title": "EMBO J"}, {"issue": "8", "key": "2_CR64", "doi-asserted-by": "publisher", "first-page": "2259", "DOI": "10.1073/pnas.0308762101", "volume": "101", "author": "J Luo", "year": "2004", "unstructured": "Luo J, Li M, Tang Y, Laszkowska M, Roeder RG, Gu W. Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci U S A. 2004;101(8):2259\u201364.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "18", "key": "2_CR65", "doi-asserted-by": "publisher", "first-page": "6891", "DOI": "10.1128/MCB.20.18.6891-6903.2000", "volume": "20", "author": "K Ito", "year": "2000", "unstructured": "Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol. 2000;20(18):6891\u2013903.", "journal-title": "Mol Cell Biol"}, {"issue": "3", "key": "2_CR66", "doi-asserted-by": "publisher", "first-page": "338", "DOI": "10.1038/77124", "volume": "25", "author": "KD Robertson", "year": "2000", "unstructured": "Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet. 2000;25(3):338\u201342. doi:\n                10.1038/77124\n                \n              .", "journal-title": "Nat Genet"}, {"issue": "23", "key": "2_CR67", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1017/S1462399407000415", "volume": "9", "author": "JH Roelfsema", "year": "2007", "unstructured": "Roelfsema JH, Peters DJ. Rubinstein-Taybi syndrome: clinical and molecular overview. Expert Rev Mol Med. 2007;9(23):1\u201316. doi:\n                10.1017/s1462399407000415\n                \n              .", "journal-title": "Expert Rev Mol Med"}, {"issue": "7", "key": "2_CR68", "first-page": "1565", "volume": "12", "author": "M Muraoka", "year": "1996", "unstructured": "Muraoka M, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Shitara N, Chong JM, Iwama T, Miyaki M. p300 gene alterations in colorectal and gastric carcinomas. Oncogene. 1996;12(7):1565\u20139.", "journal-title": "Oncogene"}, {"issue": "5", "key": "2_CR69", "doi-asserted-by": "publisher", "first-page": "566", "DOI": "10.1038/ng1773", "volume": "38", "author": "S Ropero", "year": "2006", "unstructured": "Ropero S, Fraga MF, Ballestar E, Hamelin R, Yamamoto H, Boix-Chornet M, Caballero R, Alaminos M, Setien F, Paz MF, Herranz M, Palacios J, Arango D, Orntoft TF, Aaltonen LA, Schwartz Jr S, Esteller M. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition. Nat Genet. 2006;38(5):566\u20139. doi:\n                10.1038/ng1773\n                \n              .", "journal-title": "Nat Genet"}, {"issue": "8", "key": "2_CR70", "doi-asserted-by": "publisher", "first-page": "2318", "DOI": "10.1245/s10434-008-9940-z", "volume": "15", "author": "M Ouaissi", "year": "2008", "unstructured": "Ouaissi M, Sielezneff I, Silvestre R, Sastre B, Bernard JP, Lafontaine JS, Payan MJ, Dahan L, Pirro N, Seitz JF, Mas E, Lombardo D, Ouaissi A. High histone deacetylase 7 (HDAC7) expression is significantly associated with adenocarcinomas of the pancreas. Ann Surg Oncol. 2008;15(8):2318\u201328. doi:\n                10.1245/s10434-008-9940-z\n                \n              .", "journal-title": "Ann Surg Oncol"}, {"issue": "4", "key": "2_CR71", "doi-asserted-by": "publisher", "first-page": "1245", "DOI": "10.1016/j.bbrc.2006.07.185", "volume": "348", "author": "J Bai", "year": "2006", "unstructured": "Bai J, Demirjian A, Sui J, Marasco W, Callery MP. Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells. Biochem Biophys Res Commun. 2006;348(4):1245\u201353. doi:\n                10.1016/j.bbrc.2006.07.185\n                \n              .", "journal-title": "Biochem Biophys Res Commun"}, {"issue": "1", "key": "2_CR72", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1038/sj.bjc.6603511", "volume": "96", "author": "O Ammerpohl", "year": "2007", "unstructured": "Ammerpohl O, Trauzold A, Schniewind B, Griep U, Pilarsky C, Grutzmann R, Saeger HD, Janssen O, Sipos B, Kloppel G, Kalthoff H. Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells. Br J Cancer. 2007;96(1):73\u201381. doi:\n                10.1038/sj.bjc.6603511\n                \n              .", "journal-title": "Br J Cancer"}, {"issue": "1", "key": "2_CR73", "doi-asserted-by": "publisher", "first-page": "18", "DOI": "10.1158/1078-0432.CCR-06-0914", "volume": "13", "author": "NB Arnold", "year": "2007", "unstructured": "Arnold NB, Arkus N, Gunn J, Korc M. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances gemcitabine-induced cell death in pancreatic cancer. Clin Cancer Res. 2007;13(1):18\u201326. doi:\n                10.1158/1078-0432.ccr-06-0914\n                \n              .", "journal-title": "Clin Cancer Res"}, {"issue": "1", "key": "2_CR74", "doi-asserted-by": "publisher", "first-page": "26", "DOI": "10.1101/gad.13.1.26", "volume": "13", "author": "CP Walsh", "year": "1999", "unstructured": "Walsh CP, Bestor TH. Cytosine methylation and mammalian development. Genes Dev. 1999;13(1):26\u201334.", "journal-title": "Genes Dev"}, {"issue": "5", "key": "2_CR75", "doi-asserted-by": "publisher", "first-page": "542", "DOI": "10.1007/s00018-006-6453-4", "volume": "64", "author": "DV Babushok", "year": "2007", "unstructured": "Babushok DV, Ostertag EM, Kazazian Jr HH. Current topics in genome evolution: molecular mechanisms of new gene formation. Cell Mol Life Sci. 2007;64(5):542\u201354. doi:\n                10.1007/s00018-006-6453-4\n                \n              .", "journal-title": "Cell Mol Life Sci"}, {"issue": "11", "key": "2_CR76", "doi-asserted-by": "publisher", "first-page": "6227", "DOI": "10.1128/JVI.77.11.6227-6234.2003", "volume": "77", "author": "V Badal", "year": "2003", "unstructured": "Badal V, Chuang LS, Tan EH, Badal S, Villa LL, Wheeler CM, Li BF, Bernard HU. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol. 2003;77(11):6227\u201334.", "journal-title": "J Virol"}, {"issue": "21", "key": "2_CR77", "doi-asserted-by": "publisher", "first-page": "10700", "DOI": "10.1128/JVI.01204-06", "volume": "80", "author": "IA Hutchings", "year": "2006", "unstructured": "Hutchings IA, Tierney RJ, Kelly GL, Stylianou J, Rickinson AB, Bell AI. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines. J Virol. 2006;80(21):10700\u201311. doi:\n                10.1128/jvi.01204-06\n                \n              .", "journal-title": "J Virol"}, {"issue": "1", "key": "2_CR78", "doi-asserted-by": "publisher", "first-page": "52", "DOI": "10.1016/S0006-291X(03)01121-5", "volume": "307", "author": "B Cho", "year": "2003", "unstructured": "Cho B, Lee H, Jeong S, Bang YJ, Lee HJ, Hwang KS, Kim HY, Lee YS, Kang GH, Jeoung DI. Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma. Biochem Biophys Res Commun. 2003;307(1):52\u201363.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "2_CR79", "doi-asserted-by": "publisher", "first-page": "218", "DOI": "10.1196/annals.1378.068", "volume": "1091", "author": "TS Lee", "year": "2006", "unstructured": "Lee TS, Kim JW, Kang GH, Park NH, Song YS, Kang SB, Lee HP. DNA hypomethylation of CAGE promotors in squamous cell carcinoma of uterine cervix. Ann N Y Acad Sci. 2006;1091:218\u201324. doi:\n                10.1196/annals.1378.068\n                \n              .", "journal-title": "Ann N Y Acad Sci"}, {"issue": "1", "key": "2_CR80", "doi-asserted-by": "publisher", "first-page": "48", "DOI": "10.1038/labinvest.3700696", "volume": "88", "author": "M Watanabe", "year": "2008", "unstructured": "Watanabe M, Ogawa Y, Itoh K, Koiwa T, Kadin ME, Watanabe T, Okayasu I, Higashihara M, Horie R. Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma. Lab Invest. 2008;88(1):48\u201357. doi:\n                10.1038/labinvest.3700696\n                \n              .", "journal-title": "Lab Invest"}, {"issue": "3", "key": "2_CR81", "first-page": "663", "volume": "19", "author": "SJ Kim", "year": "2008", "unstructured": "Kim SJ, Kang HS, Chang HL, Jung YC, Sim HB, Lee KS, Ro J, Lee ES. Promoter hypomethylation of the N-acetyltransferase 1 gene in breast cancer. Oncol Rep. 2008;19(3):663\u20138.", "journal-title": "Oncol Rep"}, {"issue": "10", "key": "2_CR82", "doi-asserted-by": "publisher", "first-page": "1037", "DOI": "10.1038/cr.2008.270", "volume": "18", "author": "K Tabu", "year": "2008", "unstructured": "Tabu K, Sasai K, Kimura T, Wang L, Aoyanagi E, Kohsaka S, Tanino M, Nishihara H, Tanaka S. Promoter hypomethylation regulates CD133 expression in human gliomas. Cell Res. 2008;18(10):1037\u201346. doi:\n                10.1038/cr.2008.270\n                \n              .", "journal-title": "Cell Res"}, {"issue": "8", "key": "2_CR83", "doi-asserted-by": "publisher", "first-page": "1531", "DOI": "10.1038/sj.onc.1207269", "volume": "23", "author": "N Sato", "year": "2004", "unstructured": "Sato N, Fukushima N, Matsubayashi H, Goggins M. Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene. 2004;23(8):1531\u20138. doi:\n                10.1038/sj.onc.1207269\n                \n              .", "journal-title": "Oncogene"}, {"issue": "1", "key": "2_CR84", "doi-asserted-by": "publisher", "first-page": "39", "DOI": "10.1016/j.ccr.2004.11.024", "volume": "7", "author": "ME Fernandez-Zapico", "year": "2005", "unstructured": "Fernandez-Zapico ME, Gonzalez-Paz NC, Weiss E, Savoy DN, Molina JR, Fonseca R, Smyrk TC, Chari ST, Urrutia R, Billadeau DD. Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. Cancer Cell. 2005;7(1):39\u201349. doi:\n                10.1016/j.ccr.2004.11.024\n                \n              .", "journal-title": "Cancer Cell"}, {"issue": "2", "key": "2_CR85", "first-page": "131", "volume": "6", "author": "CA Foss", "year": "2007", "unstructured": "Foss CA, Fox JJ, Feldmann G, Maitra A, Iacobuzio-Donohue C, Kern SE, Hruban R, Pomper MG. Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: initial imaging in experimental models of pancreatic cancer. Mol Imaging. 2007;6(2):131\u20139.", "journal-title": "Mol Imaging"}, {"issue": "2", "key": "2_CR86", "doi-asserted-by": "publisher", "first-page": "286", "DOI": "10.1158/1535-7163.MCT-07-0483", "volume": "7", "author": "M Li", "year": "2008", "unstructured": "Li M, Bharadwaj U, Zhang R, Zhang S, Mu H, Fisher WE, Brunicardi FC, Chen C, Yao Q. Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer. Mol Cancer Ther. 2008;7(2):286\u201396. doi:\n                10.1158/1535-7163.mct-07-0483\n                \n              .", "journal-title": "Mol Cancer Ther"}, {"issue": "6", "key": "2_CR87", "doi-asserted-by": "publisher", "first-page": "833", "DOI": "10.1002/(SICI)1097-0215(19980911)77:6<833::AID-IJC6>3.0.CO;2-V", "volume": "77", "author": "A Narayan", "year": "1998", "unstructured": "Narayan A, Ji W, Zhang XY, Marrogi A, Graff JR, Baylin SB, Ehrlich M. Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int J Cancer. 1998;77(6):833\u20138.", "journal-title": "Int J Cancer"}, {"issue": "1", "key": "2_CR88", "doi-asserted-by": "publisher", "first-page": "34", "DOI": "10.1016/S0165-4608(98)00143-5", "volume": "109", "author": "GZ Qu", "year": "1999", "unstructured": "Qu GZ, Grundy PE, Narayan A, Ehrlich M. Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. Cancer Genet Cytogenet. 1999;109(1):34\u20139.", "journal-title": "Cancer Genet Cytogenet"}, {"issue": "1-2", "key": "2_CR89", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1159/000015590", "volume": "89", "author": "C.M. Tuck-Muller", "year": "2000", "unstructured": "Tuck-Muller CM, Narayan A, Tsien F, Smeets DF, Sawyer J, Fiala ES, Sohn OS, Ehrlich M. DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients. Cytogenet Cell Genet. 2000;89(1\u20132):121\u20138. doi:10.1159/000015590.", "journal-title": "Cytogenetic and Genome Research"}, {"issue": "6", "key": "2_CR90", "doi-asserted-by": "publisher", "first-page": "2545", "DOI": "10.1073/pnas.94.6.2545", "volume": "94", "author": "C Lengauer", "year": "1997", "unstructured": "Lengauer C, Kinzler KW, Vogelstein B. DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci U S A. 1997;94(6):2545\u201350.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "6697", "key": "2_CR91", "doi-asserted-by": "publisher", "first-page": "89", "DOI": "10.1038/25779", "volume": "395", "author": "RZ Chen", "year": "1998", "unstructured": "Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R. DNA hypomethylation leads to elevated mutation rates. Nature. 1998;395(6697):89\u201393. doi:\n                10.1038/25779\n                \n              .", "journal-title": "Nature"}, {"issue": "5618", "key": "2_CR92", "doi-asserted-by": "publisher", "first-page": "455", "DOI": "10.1126/science.1083557", "volume": "300", "author": "A Eden", "year": "2003", "unstructured": "Eden A, Gaudet F, Waghmare A, Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science. 2003;300(5618):455. doi:\n                10.1126/science.1083557\n                \n              .", "journal-title": "Science"}, {"issue": "5618", "key": "2_CR93", "doi-asserted-by": "publisher", "first-page": "489", "DOI": "10.1126/science.1083558", "volume": "300", "author": "F Gaudet", "year": "2003", "unstructured": "Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science. 2003;300(5618):489\u201392. doi:\n                10.1126/science.1083558\n                \n              .", "journal-title": "Science"}, {"issue": "18", "key": "2_CR94", "doi-asserted-by": "publisher", "first-page": "2636", "DOI": "10.1038/sj.onc.1209145", "volume": "25", "author": "M Ehrlich", "year": "2006", "unstructured": "Ehrlich M, Woods CB, Yu MC, Dubeau L, Yang F, Campan M, Weisenberger DJ, Long T, Youn B, Fiala ES, Laird PW. Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors. Oncogene. 2006;25(18):2636\u201345. doi:\n                10.1038/sj.onc.1209145\n                \n              .", "journal-title": "Oncogene"}, {"issue": "4", "key": "2_CR95", "doi-asserted-by": "publisher", "first-page": "253", "DOI": "10.1080/08916930802024202", "volume": "41", "author": "M Ehrlich", "year": "2008", "unstructured": "Ehrlich M, Sanchez C, Shao C, Nishiyama R, Kehrl J, Kuick R, Kubota T, Hanash SM. ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation. Autoimmunity. 2008;41(4):253\u201371. doi:\n                10.1080/08916930802024202\n                \n              .", "journal-title": "Autoimmunity"}, {"issue": "9", "key": "2_CR96", "first-page": "1894", "volume": "55", "author": "IP Pogribny", "year": "1995", "unstructured": "Pogribny IP, Basnakian AG, Miller BJ, Lopatina NG, Poirier LA, James SJ. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. Cancer Res. 1995;55(9):1894\u2013901.", "journal-title": "Cancer Res"}, {"issue": "5", "key": "2_CR97", "doi-asserted-by": "publisher", "first-page": "1044", "DOI": "10.1086/301825", "volume": "62", "author": "NM Put van der", "year": "1998", "unstructured": "van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet. 1998;62(5):1044\u201351. doi:\n                10.1086/301825\n                \n              .", "journal-title": "Am J Hum Genet"}, {"issue": "3", "key": "2_CR98", "doi-asserted-by": "publisher", "first-page": "248", "DOI": "10.1093/aje/kwh214", "volume": "160", "author": "HG Skinner", "year": "2004", "unstructured": "Skinner HG, Michaud DS, Giovannucci EL, Rimm EB, Stampfer MJ, Willett WC, Colditz GA, Fuchs CS. A prospective study of folate intake and the risk of pancreatic cancer in men and women. Am J Epidemiol. 2004;160(3):248\u201358. doi:\n                10.1093/aje/kwh214\n                \n              .", "journal-title": "Am J Epidemiol"}, {"issue": "4", "key": "2_CR99", "first-page": "310", "volume": "2", "author": "N Omura", "year": "2009", "unstructured": "Omura N, Goggins M. Epigenetics and epigenetic alterations in pancreatic cancer. Int J Clin Exp Pathol. 2009;2(4):310\u201326.", "journal-title": "Int J Clin Exp Pathol"}, {"issue": "23", "key": "2_CR100", "doi-asserted-by": "publisher", "first-page": "3215", "DOI": "10.1101/gad.1464906", "volume": "20", "author": "AH Ting", "year": "2006", "unstructured": "Ting AH, McGarvey KM, Baylin SB. The cancer epigenome\u2014components and functional correlates. Genes Dev. 2006;20(23):3215\u201331. doi:\n                10.1101/gad.1464906\n                \n              .", "journal-title": "Genes Dev"}, {"issue": "R1", "key": "2_CR101", "doi-asserted-by": "publisher", "first-page": "R50", "DOI": "10.1093/hmg/ddm018", "volume": "16", "author": "Manel Esteller", "year": "2007", "unstructured": "Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet. 2007;16 Spec No 1:R50\u201359. doi:\n                10.1093/hmg/ddm018\n                \n              .", "journal-title": "Human Molecular Genetics"}, {"issue": "2", "key": "2_CR102", "first-page": "412", "volume": "70", "author": "SB Baylin", "year": "1987", "unstructured": "Baylin SB, Fearon ER, Vogelstein B, de Bustros A, Sharkis SJ, Burke PJ, Staal SP, Nelkin BD. Hypermethylation of the 5\u2032 region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies. Blood. 1987;70(2):412\u20137.", "journal-title": "Blood"}, {"issue": "2", "key": "2_CR103", "doi-asserted-by": "publisher", "first-page": "155", "DOI": "10.1007/BF00286709", "volume": "83", "author": "V Greger", "year": "1989", "unstructured": "Greger V, Passarge E, Hopping W, Messmer E, Horsthemke B. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet. 1989;83(2):155\u20138.", "journal-title": "Hum Genet"}, {"issue": "1", "key": "2_CR104", "doi-asserted-by": "publisher", "first-page": "85", "DOI": "10.2174/156652407779940413", "volume": "7", "author": "DS Shames", "year": "2007", "unstructured": "Shames DS, Minna JD, Gazdar AF. DNA methylation in health, disease, and cancer. Curr Mol Med. 2007;7(1):85\u2013102.", "journal-title": "Curr Mol Med"}, {"issue": "7", "key": "2_CR105", "first-page": "1835", "volume": "60", "author": "T Ueki", "year": "2000", "unstructured": "Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH, Goggins M. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res. 2000;60(7):1835\u20139.", "journal-title": "Cancer Res"}, {"issue": "1", "key": "2_CR106", "doi-asserted-by": "publisher", "first-page": "70", "DOI": "10.4161/cbt.4.1.1378", "volume": "4", "author": "N Sato", "year": "2005", "unstructured": "Sato N, Matsubayashi H, Fukushima N, Goggins M. The chemokine receptor CXCR4 is regulated by DNA methylation in pancreatic cancer. Cancer Biol Ther. 2005;4(1):70\u20136.", "journal-title": "Cancer Biol Ther"}, {"issue": "4", "key": "2_CR107", "doi-asserted-by": "publisher", "first-page": "286", "DOI": "10.1007/s00534-005-1057-1", "volume": "13", "author": "N Sato", "year": "2006", "unstructured": "Sato N, Goggins M. The role of epigenetic alterations in pancreatic cancer. J Hepatobiliary Pancreat Surg. 2006;13(4):286\u201395. doi:\n                10.1007/s00534-005-1057-1\n                \n              .", "journal-title": "J Hepatobiliary Pancreat Surg"}, {"issue": "8", "key": "2_CR108", "doi-asserted-by": "publisher", "first-page": "1850", "DOI": "10.1002/ijc.22047", "volume": "119", "author": "N Yamada", "year": "2006", "unstructured": "Yamada N, Hamada T, Goto M, Tsutsumida H, Higashi M, Nomoto M, Yonezawa S. MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer. Int J Cancer. 2006;119(8):1850\u20137. doi:\n                10.1002/ijc.22047\n                \n              .", "journal-title": "Int J Cancer"}, {"issue": "2", "key": "2_CR109", "doi-asserted-by": "publisher", "first-page": "548", "DOI": "10.1053/j.gastro.2005.11.008", "volume": "130", "author": "N Sato", "year": "2006", "unstructured": "Sato N, Fukushima N, Chang R, Matsubayashi H, Goggins M. Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers. Gastroenterology. 2006;130(2):548\u201365. doi:\n                10.1053/j.gastro.2005.11.008\n                \n              .", "journal-title": "Gastroenterology"}, {"issue": "7", "key": "2_CR110", "doi-asserted-by": "publisher", "first-page": "728", "DOI": "10.4161/cbt.4.7.1802", "volume": "4", "author": "ST Martin", "year": "2005", "unstructured": "Martin ST, Sato N, Dhara S, Chang R, Hustinx SR, Abe T, Maitra A, Goggins M. Aberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms. Cancer Biol Ther. 2005;4(7):728\u201333.", "journal-title": "Cancer Biol Ther"}, {"issue": "6960", "key": "2_CR111", "doi-asserted-by": "publisher", "first-page": "846", "DOI": "10.1038/nature01972", "volume": "425", "author": "DM Berman", "year": "2003", "unstructured": "Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN, Beachy PA. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature. 2003;425(6960):846\u201351. doi:\n                10.1038/nature01972\n                \n              .", "journal-title": "Nature"}, {"issue": "6960", "key": "2_CR112", "doi-asserted-by": "publisher", "first-page": "851", "DOI": "10.1038/nature02009", "volume": "425", "author": "SP Thayer", "year": "2003", "unstructured": "Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernandez-del Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw AL, Hebrok M. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature. 2003;425(6960):851\u20136. doi:\n                10.1038/nature02009\n                \n              .", "journal-title": "Nature"}, {"issue": "10", "key": "2_CR113", "doi-asserted-by": "publisher", "first-page": "1420", "DOI": "10.1136/gut.2007.148189", "volume": "57", "author": "G Feldmann", "year": "2008", "unstructured": "Feldmann G, Habbe N, Dhara S, Bisht S, Alvarez H, Fendrich V, Beaty R, Mullendore M, Karikari C, Bardeesy N, Ouellette MM, Yu W, Maitra A. Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer. Gut. 2008;57(10):1420\u201330. doi:\n                10.1136/gut.2007.148189\n                \n              .", "journal-title": "Gut"}, {"issue": "7", "key": "2_CR114", "first-page": "3139", "volume": "61", "author": "H Yamamoto", "year": "2001", "unstructured": "Yamamoto H, Itoh F, Nakamura H, Fukushima H, Sasaki S, Perucho M, Imai K. Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability. Cancer Res. 2001;61(7):3139\u201344.", "journal-title": "Cancer Res"}, {"issue": "8", "key": "2_CR115", "first-page": "2536", "volume": "8", "author": "B Nakata", "year": "2002", "unstructured": "Nakata B, Wang YQ, Yashiro M, Nishioka N, Tanaka H, Ohira M, Ishikawa T, Nishino H, Hirakawa K. Prognostic value of microsatellite instability in resectable pancreatic cancer. Clin Cancer Res. 2002;8(8):2536\u201340.", "journal-title": "Clin Cancer Res"}, {"issue": "6", "key": "2_CR116", "first-page": "1501", "volume": "152", "author": "M Goggins", "year": "1998", "unstructured": "Goggins M, Offerhaus GJ, Hilgers W, Griffin CA, Shekher M, Tang D, Sohn TA, Yeo CJ, Kern SE, Hruban RH. Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am J Pathol. 1998;152(6):1501\u20137.", "journal-title": "Am J Pathol"}, {"issue": "5", "key": "2_CR117", "doi-asserted-by": "publisher", "first-page": "1641", "DOI": "10.1016/S0002-9440(10)65035-3", "volume": "156", "author": "RE Wilentz", "year": "2000", "unstructured": "Wilentz RE, Goggins M, Redston M, Marcus VA, Adsay NV, Sohn TA, Kadkol SS, Yeo CJ, Choti M, Zahurak M, Johnson K, Tascilar M, Offerhaus GJ, Hruban RH, Kern SE. Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: a newly described and characterized entity. Am J Pathol. 2000;156(5):1641\u201351. doi:\n                10.1016/s0002-9440(10)65035-3\n                \n              .", "journal-title": "Am J Pathol"}, {"issue": "1", "key": "2_CR118", "doi-asserted-by": "publisher", "first-page": "31", "DOI": "10.1016/S0014-5793(00)01902-5", "volume": "481", "author": "H Izumi", "year": "2000", "unstructured": "Izumi H, Takahashi C, Oh J, Noda M. Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes. FEBS Lett. 2000;481(1):31\u20136.", "journal-title": "FEBS Lett"}, {"issue": "2", "key": "2_CR119", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1006/gyno.2001.6394", "volume": "83", "author": "M Jin", "year": "2001", "unstructured": "Jin M, Udagawa K, Miyagi E, Nakazawa T, Hirahara F, Yasumitsu H, Miyazaki K, Nagashima Y, Aoki I, Miyagi Y. Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo. Gynecol Oncol. 2001;83(2):325\u201333. doi:\n                10.1006/gyno.2001.6394\n                \n              .", "journal-title": "Gynecol Oncol"}, {"issue": "5", "key": "2_CR120", "doi-asserted-by": "publisher", "first-page": "850", "DOI": "10.1038/sj.onc.1208050", "volume": "24", "author": "N Sato", "year": "2005", "unstructured": "Sato N, Parker AR, Fukushima N, Miyagi Y, Iacobuzio-Donahue CA, Eshleman JR, Goggins M. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. Oncogene. 2005;24(5):850\u20138. doi:\n                10.1038/sj.onc.1208050\n                \n              .", "journal-title": "Oncogene"}, {"issue": "15", "key": "2_CR121", "doi-asserted-by": "publisher", "first-page": "5338", "DOI": "10.1158/0008-5472.CAN-04-0089", "volume": "64", "author": "J Okami", "year": "2004", "unstructured": "Okami J, Simeone DM, Logsdon CD. Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer. Cancer Res. 2004;64(15):5338\u201346. doi:\n                10.1158/0008-5472.can-04-0089\n                \n              .", "journal-title": "Cancer Res"}, {"issue": "5", "key": "2_CR122", "doi-asserted-by": "publisher", "first-page": "504", "DOI": "10.1007/s00535-005-1576-1", "volume": "40", "author": "T Abe", "year": "2005", "unstructured": "Abe T, Toyota M, Suzuki H, Murai M, Akino K, Ueno M, Nojima M, Yawata A, Miyakawa H, Suga T, Ito H, Endo T, Tokino T, Hinoda Y, Imai K. Upregulation of BNIP3 by 5-aza-2\u2032-deoxycytidine sensitizes pancreatic cancer cells to hypoxia-mediated cell death. J Gastroenterol. 2005;40(5):504\u201310. doi:\n                10.1007/s00535-005-1576-1\n                \n              .", "journal-title": "J Gastroenterol"}, {"issue": "8", "key": "2_CR123", "doi-asserted-by": "publisher", "first-page": "3094", "DOI": "10.1158/1078-0432.CCR-04-1785", "volume": "11", "author": "M Akada", "year": "2005", "unstructured": "Akada M, Crnogorac-Jurcevic T, Lattimore S, Mahon P, Lopes R, Sunamura M, Matsuno S, Lemoine NR. Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer. Clin Cancer Res. 2005;11(8):3094\u2013101. doi:\n                10.1158/1078-0432.ccr-04-1785\n                \n              .", "journal-title": "Clin Cancer Res"}, {"issue": "10", "key": "2_CR124", "doi-asserted-by": "publisher", "first-page": "1546", "DOI": "10.4161/cbt.6.10.4708", "volume": "6", "author": "B Fu", "year": "2007", "unstructured": "Fu B, Guo M, Wang S, Campagna D, Luo M, Herman JG, Iacobuzio-Donahue CA. Evaluation of GATA-4 and GATA-5 methylation profiles in human pancreatic cancers indicate promoter methylation patterns distinct from other human tumor types. Cancer Biol Ther. 2007;6(10):1546\u201352.", "journal-title": "Cancer Biol Ther"}, {"issue": "2", "key": "2_CR125", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1096/fasebj.8.2.8119487", "volume": "8", "author": "TF Lane", "year": "1994", "unstructured": "Lane TF, Sage EH. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 1994;8(2):163\u201373.", "journal-title": "FASEB J"}, {"issue": "32", "key": "2_CR126", "doi-asserted-by": "publisher", "first-page": "5021", "DOI": "10.1038/sj.onc.1206807", "volume": "22", "author": "N Sato", "year": "2003", "unstructured": "Sato N, Fukushima N, Maehara N, Matsubayashi H, Koopmann J, Su GH, Hruban RH, Goggins M. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions. Oncogene. 2003;22(32):5021\u201330. doi:\n                10.1038/sj.onc.1206807\n                \n              .", "journal-title": "Oncogene"}, {"issue": "9", "key": "2_CR127", "first-page": "1895", "volume": "12", "author": "SC Mok", "year": "1996", "unstructured": "Mok SC, Chan WY, Wong KK, Muto MG, Berkowitz RS. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. Oncogene. 1996;12(9):1895\u2013901.", "journal-title": "Oncogene"}, {"issue": "21", "key": "2_CR128", "first-page": "6270", "volume": "62", "author": "C Schultz", "year": "2002", "unstructured": "Schultz C, Lemke N, Ge S, Golembieski WA, Rempel SA. Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. Cancer Res. 2002;62(21):6270\u20137.", "journal-title": "Cancer Res"}, {"issue": "7", "key": "2_CR129", "doi-asserted-by": "publisher", "first-page": "1146", "DOI": "10.4161/cbt.7.7.6208", "volume": "7", "author": "N Omura", "year": "2008", "unstructured": "Omura N, Li CP, Li A, Hong SM, Walter K, Jimeno A, Hidalgo M, Goggins M. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma. Cancer Biol Ther. 2008;7(7):1146\u201356.", "journal-title": "Cancer Biol Ther"}, {"issue": "5", "key": "2_CR130", "doi-asserted-by": "publisher", "first-page": "1573", "DOI": "10.1016/S0002-9440(10)61104-2", "volume": "160", "author": "N Fukushima", "year": "2002", "unstructured": "Fukushima N, Sato N, Ueki T, Rosty C, Walter KM, Wilentz RE, Yeo CJ, Hruban RH, Goggins M. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Am J Pathol. 2002;160(5):1573\u201381. doi:\n                10.1016/s0002-9440(10)61104-2\n                \n              .", "journal-title": "Am J Pathol"}, {"issue": "6", "key": "2_CR131", "doi-asserted-by": "publisher", "first-page": "639", "DOI": "10.1101/gad.9.6.639", "volume": "9", "author": "MH Lee", "year": "1995", "unstructured": "Lee MH, Reynisdottir I, Massague J. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 1995;9(6):639\u201349.", "journal-title": "Genes Dev"}, {"issue": "6", "key": "2_CR132", "doi-asserted-by": "publisher", "first-page": "650", "DOI": "10.1101/gad.9.6.650", "volume": "9", "author": "S Matsuoka", "year": "1995", "unstructured": "Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 1995;9(6):650\u201362.", "journal-title": "Genes Dev"}, {"issue": "12", "key": "2_CR133", "doi-asserted-by": "publisher", "first-page": "1499", "DOI": "10.1038/modpathol.2008.157", "volume": "21", "author": "SM Hong", "year": "2008", "unstructured": "Hong SM, Kelly D, Griffith M, Omura N, Li A, Li CP, Hruban RH, Goggins M. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas. Mod Pathol. 2008;21(12):1499\u2013507. doi:\n                10.1038/modpathol.2008.157\n                \n              .", "journal-title": "Mod Pathol"}, {"issue": "1", "key": "2_CR134", "doi-asserted-by": "publisher", "first-page": "365", "DOI": "10.1053/gast.2002.34160", "volume": "123", "author": "N Sato", "year": "2002", "unstructured": "Sato N, Ueki T, Fukushima N, Iacobuzio-Donahue CA, Yeo CJ, Cameron JL, Hruban RH, Goggins M. Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology. 2002;123(1):365\u201372.", "journal-title": "Gastroenterology"}, {"issue": "8", "key": "2_CR135", "doi-asserted-by": "publisher", "first-page": "1735", "DOI": "10.1158/1535-7163.MCT-12-0037", "volume": "11", "author": "A Avan", "year": "2012", "unstructured": "Avan A, Crea F, Paolicchi E, Funel N, Galvani E, Marquez VE, Honeywell RJ, Danesi R, Peters GJ, Giovannetti E. Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells. Mol Cancer Ther. 2012;11(8):1735\u201346. doi:\n                10.1158/1535-7163.mct-12-0037\n                \n              .", "journal-title": "Mol Cancer Ther"}, {"issue": "1", "key": "2_CR136", "doi-asserted-by": "publisher", "first-page": "86", "DOI": "10.1016/j.ccr.2010.10.035", "volume": "19", "author": "CJ Chang", "year": "2011", "unstructured": "Chang CJ, Yang JY, Xia W, Chen CT, Xie X, Chao CH, Woodward WA, Hsu JM, Hortobagyi GN, Hung MC. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-beta-catenin signaling. Cancer Cell. 2011;19(1):86\u2013100. doi:\n                10.1016/j.ccr.2010.10.035\n                \n              .", "journal-title": "Cancer Cell"}, {"issue": "11", "key": "2_CR137", "doi-asserted-by": "publisher", "first-page": "2557", "DOI": "10.1002/ijc.26264", "volume": "130", "author": "T Chiba", "year": "2012", "unstructured": "Chiba T, Suzuki E, Negishi M, Saraya A, Miyagi S, Konuma T, Tanaka S, Tada M, Kanai F, Imazeki F, Iwama A, Yokosuka O. 3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells. Int J Cancer. 2012;130(11):2557\u201367. doi:\n                10.1002/ijc.26264\n                \n              .", "journal-title": "Int J Cancer"}, {"key": "2_CR138", "doi-asserted-by": "publisher", "first-page": "40", "DOI": "10.1186/1476-4598-10-40", "volume": "10", "author": "F Crea", "year": "2011", "unstructured": "Crea F, Hurt EM, Mathews LA, Cabarcas SM, Sun L, Marquez VE, Danesi R, Farrar WL. Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer. Mol Cancer. 2011;10:40. doi:\n                10.1186/1476-4598-10-40\n                \n              .", "journal-title": "Mol Cancer"}, {"issue": "2", "key": "2_CR139", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1158/1535-7163.MCT-10-0788", "volume": "10", "author": "S Rizzo", "year": "2011", "unstructured": "Rizzo S, Hersey JM, Mellor P, Dai W, Santos-Silva A, Liber D, Luk L, Titley I, Carden CP, Box G, Hudson DL, Kaye SB, Brown R. Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2. Mol Cancer Ther. 2011;10(2):325\u201335. doi:\n                10.1158/1535-7163.mct-10-0788\n                \n              .", "journal-title": "Mol Cancer Ther"}, {"issue": "3", "key": "2_CR140", "doi-asserted-by": "publisher", "first-page": "309", "DOI": "10.1186/bcr2871", "volume": "13", "author": "OA Stefansson", "year": "2011", "unstructured": "Stefansson OA, Esteller M. EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells. Breast Cancer Res. 2011;13(3):309. doi:\n                10.1186/bcr2871\n                \n              .", "journal-title": "Breast Cancer Res"}, {"issue": "1", "key": "2_CR141", "doi-asserted-by": "publisher", "first-page": "43", "DOI": "10.5966/sctm.2012-0036", "volume": "2", "author": "LE Vlerken van", "year": "2013", "unstructured": "van Vlerken LE, Kiefer CM, Morehouse C, Li Y, Groves C, Wilson SD, Yao Y, Hollingsworth RE, Hurt EM. EZH2 is required for breast and pancreatic cancer stem cell maintenance and can be used as a functional cancer stem cell reporter. Stem Cells Transl Med. 2013;2(1):43\u201352. doi:\n                10.5966/sctm.2012-0036\n                \n              .", "journal-title": "Stem Cells Transl Med"}, {"issue": "8", "key": "2_CR142", "doi-asserted-by": "publisher", "first-page": "966", "DOI": "10.1007/s00535-011-0422-x", "volume": "46", "author": "J Dorado", "year": "2011", "unstructured": "Dorado J, Lonardo E, Miranda-Lorenzo I, Heeschen C. Pancreatic cancer stem cells: new insights and perspectives. J Gastroenterol. 2011;46(8):966\u201373. doi:\n                10.1007/s00535-011-0422-x\n                \n              .", "journal-title": "J Gastroenterol"}, {"key": "2_CR143", "doi-asserted-by": "publisher", "first-page": "161", "DOI": "10.1007/978-1-59745-280-9_10", "volume": "568", "author": "C Li", "year": "2009", "unstructured": "Li C, Lee CJ, Simeone DM. Identification of human pancreatic cancer stem cells. Methods Mol Biol. 2009;568:161\u201373. doi:\n                10.1007/978-1-59745-280-9_10\n                \n              .", "journal-title": "Methods Mol Biol"}, {"issue": "2", "key": "2_CR144", "doi-asserted-by": "publisher", "first-page": "147", "DOI": "10.1002/path.2793", "volume": "223", "author": "MR Alison", "year": "2011", "unstructured": "Alison MR, Lim SM, Nicholson LJ. Cancer stem cells: problems for therapy? J Pathol. 2011;223(2):147\u201361. doi:\n                10.1002/path.2793\n                \n              .", "journal-title": "J Pathol"}, {"issue": "12", "key": "2_CR145", "doi-asserted-by": "publisher", "first-page": "3130", "DOI": "10.1158/1078-0432.CCR-09-2846", "volume": "16", "author": "AA Merchant", "year": "2010", "unstructured": "Merchant AA, Matsui W. Targeting Hedgehog\u2014a cancer stem cell pathway. Clin Cancer Res. 2010;16(12):3130\u201340. doi:\n                10.1158/1078-0432.ccr-09-2846\n                \n              .", "journal-title": "Clin Cancer Res"}, {"issue": "14", "key": "2_CR146", "doi-asserted-by": "publisher", "first-page": "1328", "DOI": "10.4161/cbt.8.14.8633", "volume": "8", "author": "SG Chun", "year": "2009", "unstructured": "Chun SG, Zhou W, Yee NS. Combined targeting of histone deacetylases and hedgehog signaling enhances cytoxicity in pancreatic cancer. Cancer Biol Ther. 2009;8(14):1328\u201339.", "journal-title": "Cancer Biol Ther"}, {"issue": "8", "key": "2_CR147", "doi-asserted-by": "publisher", "DOI": "10.1371/journal.pone.0024099", "volume": "6", "author": "D Nalls", "year": "2011", "unstructured": "Nalls D, Tang SN, Rodova M, Srivastava RK, Shankar S. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells. PLoS One. 2011;6(8), e24099. doi:\n                10.1371/journal.pone.0024099\n                \n              .", "journal-title": "PLoS One"}, {"issue": "4", "key": "2_CR148", "doi-asserted-by": "publisher", "first-page": "698", "DOI": "10.1007/s00268-008-9833-0", "volume": "33", "author": "Y Zhang", "year": "2009", "unstructured": "Zhang Y, Li M, Wang H, Fisher WE, Lin PH, Yao Q, Chen C. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg. 2009;33(4):698\u2013709. doi:\n                10.1007/s00268-008-9833-0\n                \n              .", "journal-title": "World J Surg"}, {"issue": "17", "key": "2_CR149", "doi-asserted-by": "publisher", "first-page": "1901", "DOI": "10.1001/jama.297.17.1901", "volume": "297", "author": "M Bloomston", "year": "2007", "unstructured": "Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007;297(17):1901\u20138. doi:\n                10.1001/jama.297.17.1901\n                \n              .", "journal-title": "JAMA"}, {"issue": "30", "key": "2_CR150", "doi-asserted-by": "publisher", "first-page": "4442", "DOI": "10.1038/sj.onc.1210228", "volume": "26", "author": "AE Szafranska", "year": "2007", "unstructured": "Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, Labourier E, Hahn SA. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene. 2007;26(30):4442\u201352. doi:\n                10.1038/sj.onc.1210228\n                \n              .", "journal-title": "Oncogene"}, {"issue": "5", "key": "2_CR151", "doi-asserted-by": "publisher", "first-page": "1046", "DOI": "10.1002/ijc.22394", "volume": "120", "author": "EJ Lee", "year": "2007", "unstructured": "Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, Morgan DL, Postier RG, Brackett DJ, Schmittgen TD. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer. 2007;120(5):1046\u201354. doi:\n                10.1002/ijc.22394\n                \n              .", "journal-title": "Int J Cancer"}, {"issue": "7", "key": "2_CR152", "doi-asserted-by": "publisher", "first-page": "817", "DOI": "10.3748/wjg.v17.i7.817", "volume": "17", "author": "JY Park", "year": "2011", "unstructured": "Park JY, Helm J, Coppola D, Kim D, Malafa M, Kim SJ. MicroRNAs in pancreatic ductal adenocarcinoma. World J Gastroenterol. 2011;17(7):817\u201327. doi:\n                10.3748/wjg.v17.i7.817\n                \n              .", "journal-title": "World J Gastroenterol"}, {"issue": "8", "key": "2_CR153", "doi-asserted-by": "publisher", "first-page": "1183", "DOI": "10.1093/carcin/bgr105", "volume": "32", "author": "S Zhang", "year": "2011", "unstructured": "Zhang S, Hao J, Xie F, Hu X, Liu C, Tong J, Zhou J, Wu J, Shao C. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Carcinogenesis. 2011;32(8):1183\u20139. doi:\n                10.1093/carcin/bgr105\n                \n              .", "journal-title": "Carcinogenesis"}, {"issue": "2", "key": "2_CR154", "doi-asserted-by": "publisher", "first-page": "231", "DOI": "10.1016/j.canlet.2012.03.022", "volume": "342", "author": "S Fukushige", "year": "2014", "unstructured": "Fukushige S, Horii A. Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers. Cancer Lett. 2014;342(2):231\u20137. doi:\n                10.1016/j.canlet.2012.03.022\n                \n              .", "journal-title": "Cancer Lett"}, {"issue": "4", "key": "2_CR155", "doi-asserted-by": "publisher", "first-page": "340", "DOI": "10.4161/cbt.8.4.7338", "volume": "8", "author": "N Habbe", "year": "2009", "unstructured": "Habbe N, Koorstra JB, Mendell JT, Offerhaus GJ, Ryu JK, Feldmann G, Mullendore ME, Goggins MG, Hong SM, Maitra A. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther. 2009;8(4):340\u20136.", "journal-title": "Cancer Biol Ther"}, {"issue": "9", "key": "2_CR156", "doi-asserted-by": "publisher", "first-page": "807", "DOI": "10.1158/1940-6207.CAPR-09-0094", "volume": "2", "author": "J Wang", "year": "2009", "unstructured": "Wang J, Chen J, Chang P, LeBlanc A, Li D, Abbruzzesse JL, Frazier ML, Killary AM, Sen S. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res. 2009;2(9):807\u201313. doi:\n                10.1158/1940-6207.capr-09-0094\n                \n              .", "journal-title": "Cancer Prev Res"}, {"issue": "2", "key": "2_CR157", "doi-asserted-by": "publisher", "first-page": "361", "DOI": "10.1038/bjc.2012.546", "volume": "108", "author": "T Kawaguchi", "year": "2013", "unstructured": "Kawaguchi T, Komatsu S, Ichikawa D, Morimura R, Tsujiura M, Konishi H, Takeshita H, Nagata H, Arita T, Hirajima S, Shiozaki A, Ikoma H, Okamoto K, Ochiai T, Taniguchi H, Otsuji E. Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer. Br J Cancer. 2013;108(2):361\u20139. doi:\n                10.1038/bjc.2012.546\n                \n              .", "journal-title": "Br J Cancer"}, {"issue": "3", "key": "2_CR158", "doi-asserted-by": "publisher", "first-page": "610", "DOI": "10.1373/clinchem.2011.172767", "volume": "58", "author": "R Liu", "year": "2012", "unstructured": "Liu R, Chen X, Du Y, Yao W, Shen L, Wang C, Hu Z, Zhuang R, Ning G, Zhang C, Yuan Y, Li Z, Zen K, Ba Y, Zhang CY. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem. 2012;58(3):610\u20138. doi:\n                10.1373/clinchem.2011.172767\n                \n              .", "journal-title": "Clin Chem"}, {"issue": "11", "key": "2_CR159", "doi-asserted-by": "publisher", "first-page": "1733", "DOI": "10.1038/bjc.2011.453", "volume": "105", "author": "R Morimura", "year": "2011", "unstructured": "Morimura R, Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Nagata H, Konishi H, Shiozaki A, Ikoma H, Okamoto K, Ochiai T, Taniguchi H, Otsuji E. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. Br J Cancer. 2011;105(11):1733\u201340. doi:\n                10.1038/bjc.2011.453\n                \n              .", "journal-title": "Br J Cancer"}, {"issue": "2", "key": "2_CR160", "doi-asserted-by": "publisher", "first-page": "602", "DOI": "10.1007/s10620-010-1285-3", "volume": "56", "author": "X Kong", "year": "2011", "unstructured": "Kong X, Du Y, Wang G, Gao J, Gong Y, Li L, Zhang Z, Zhu J, Jing Q, Qin Y, Li Z. Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Dig Dis Sci. 2011;56(2):602\u20139. doi:\n                10.1007/s10620-010-1285-3\n                \n              .", "journal-title": "Dig Dis Sci"}, {"issue": "8", "key": "2_CR161", "doi-asserted-by": "publisher", "first-page": "1352", "DOI": "10.1038/ajg.2013.167", "volume": "108", "author": "JJ Farrell", "year": "2013", "unstructured": "Farrell JJ, Toste P, Wu N, Li L, Wong J, Malkhassian D, Tran LM, Wu X, Li X, Dawson D, Wu H, Donahue TR. Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer. Am J Gastroenterol. 2013;108(8):1352\u20139. doi:\n                10.1038/ajg.2013.167\n                \n              .", "journal-title": "Am J Gastroenterol"}, {"issue": "7", "key": "2_CR162", "first-page": "2002", "volume": "60", "author": "RE Wilentz", "year": "2000", "unstructured": "Wilentz RE, Iacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, Yeo CJ, Kern SE, Hruban RH. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res. 2000;60(7):2002\u20136.", "journal-title": "Cancer Res"}, {"issue": "5", "key": "2_CR163", "doi-asserted-by": "publisher", "first-page": "646", "DOI": "10.1016/j.cell.2011.02.013", "volume": "144", "author": "D Hanahan", "year": "2011", "unstructured": "Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. doi:\n                10.1016/j.cell.2011.02.013\n                \n              .", "journal-title": "Cell"}, {"issue": "2", "key": "2_CR164", "first-page": "545", "volume": "143", "author": "RH Hruban", "year": "1993", "unstructured": "Hruban RH, van Mansfeld AD, Offerhaus GJ, van Weering DH, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol. 1993;143(2):545\u201354.", "journal-title": "Am J Pathol"}, {"issue": "4", "key": "2_CR165", "doi-asserted-by": "publisher", "DOI": "10.1371/journal.pone.0060870", "volume": "8", "author": "PS Rachakonda", "year": "2013", "unstructured": "Rachakonda PS, Bauer AS, Xie H, Campa D, Rizzato C, Canzian F, Beghelli S, Greenhalf W, Costello E, Schanne M, Heller A, Scarpa A, Neoptolemos JP, Werner J, Buchler M, Hoheisel JD, Hemminki K, Giese N, Kumar R. Somatic mutations in exocrine pancreatic tumors: association with patient survival. PLoS One. 2013;8(4), e60870. doi:\n                10.1371/journal.pone.0060870\n                \n              .", "journal-title": "PLoS One"}, {"issue": "3", "key": "2_CR166", "doi-asserted-by": "publisher", "first-page": "363", "DOI": "10.3892/etm.2012.631", "volume": "4", "author": "W Zhong", "year": "2012", "unstructured": "Zhong W, Chen W, Zhang D, Sun J, Li Y, Zhang J, Gao Y, Zhou W, Li S. CXCL12/CXCR4 axis plays pivotal roles in the organ-specific metastasis of pancreatic adenocarcinoma: a clinical study. Exp Ther Med. 2012;4(3):363\u20139. doi:\n                10.3892/etm.2012.631\n                \n              .", "journal-title": "Exp Ther Med"}, {"issue": "6041", "key": "2_CR167", "doi-asserted-by": "publisher", "first-page": "425", "DOI": "10.1126/science.1207313", "volume": "333", "author": "CM Heaphy", "year": "2011", "unstructured": "Heaphy CM, de Wilde RF, Jiao Y, Klein AP, Edil BH, Shi C, Bettegowda C, Rodriguez FJ, Eberhart CG, Hebbar S, Offerhaus GJ, McLendon R, Rasheed BA, He Y, Yan H, Bigner DD, Oba-Shinjo SM, Marie SK, Riggins GJ, Kinzler KW, Vogelstein B, Hruban RH, Maitra A, Papadopoulos N, Meeker AK. Altered telomeres in tumors with ATRX and DAXX mutations. Science. 2011;333(6041):425. doi:\n                10.1126/science.1207313\n                \n              .", "journal-title": "Science"}, {"issue": "3", "key": "2_CR168", "doi-asserted-by": "publisher", "first-page": "267", "DOI": "10.1016/j.pan.2013.02.006", "volume": "13", "author": "S Sivaprasad", "year": "2013", "unstructured": "Sivaprasad S, Govardhan B, Harithakrishna R, Venkat Rao G, Pradeep R, Kunal B, Ramakrishna N, Anuradha S, Reddy DN. Association of vascular endothelial growth factor (VEGF) gene polymorphism and increased serum VEGF concentration with pancreatic adenocarcinoma. Pancreatology. 2013;13(3):267\u201372. doi:\n                10.1016/j.pan.2013.02.006\n                \n              .", "journal-title": "Pancreatology"}, {"issue": "2", "key": "2_CR169", "first-page": "306", "volume": "1", "author": "CY Sun", "year": "2002", "unstructured": "Sun CY, Wang BL, Hu CQ, Peng RY, Gao YB, Gu QY, Wang DW. Expression of the bcl-2 gene and its significance in human pancreatic carcinoma. Hepatobiliary Pancreat Dis Int. 2002;1(2):306\u20138.", "journal-title": "Hepatobiliary Pancreat Dis Int"}, {"issue": "22", "key": "2_CR170", "doi-asserted-by": "publisher", "first-page": "3605", "DOI": "10.1200/JCO.2009.25.7550", "volume": "28", "author": "PA Philip", "year": "2010", "unstructured": "Philip PA, Benedetti J, Corless CL, Wong R, O\u2019Reilly EM, Flynn PJ, Rowland KM, Atkins JN, Mirtsching BC, Rivkin SE, Khorana AA, Goldman B, Fenoglio-Preiser CM, Abbruzzese JL, Blanke CD. Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205. J Clin Oncol. 2010;28(22):3605\u201310. doi:\n                10.1200/jco.2009.25.7550\n                \n              .", "journal-title": "J Clin Oncol"}, {"issue": "22", "key": "2_CR171", "doi-asserted-by": "publisher", "first-page": "3617", "DOI": "10.1200/JCO.2010.28.1386", "volume": "28", "author": "HL Kindler", "year": "2010", "unstructured": "Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, Innocenti F, Mulcahy MF, O\u2019Reilly E, Wozniak TF, Picus J, Bhargava P, Mayer RJ, Schilsky RL, Goldberg RM. Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). J Clin Oncol. 2010;28(22):3617\u201322. doi:\n                10.1200/jco.2010.28.1386\n                \n              .", "journal-title": "J Clin Oncol"}, {"issue": "15", "key": "2_CR172", "doi-asserted-by": "publisher", "first-page": "1960", "DOI": "10.1200/JCO.2006.07.9525", "volume": "25", "author": "MJ Moore", "year": "2007", "unstructured": "Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, Campos D, Lim R, Ding K, Clark G, Voskoglou-Nomikos T, Ptasynski M, Parulekar W. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 2007;25(15):1960\u20136. doi:\n                10.1200/jco.2006.07.9525\n                \n              .", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "2_CR173", "doi-asserted-by": "publisher", "first-page": "212", "DOI": "10.1016/j.canlet.2012.10.005", "volume": "328", "author": "AL McCleary-Wheeler", "year": "2013", "unstructured": "McCleary-Wheeler AL, Lomberk GA, Weiss FU, Schneider G, Fabbri M, Poshusta TL, Dusetti NJ, Baumgart S, Iovanna JL, Ellenrieder V, Urrutia R, Fernandez-Zapico ME. Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis. Cancer Lett. 2013;328(2):212\u201321. doi:\n                10.1016/j.canlet.2012.10.005\n                \n              .", "journal-title": "Cancer Lett"}, {"key": "2_CR174", "doi-asserted-by": "publisher", "first-page": "214143", "DOI": "10.1155/2011/214143", "volume": "2011", "author": "S Stintzing", "year": "2011", "unstructured": "Stintzing S, Kemmerling R, Kiesslich T, Alinger B, Ocker M, Neureiter D. Myelodysplastic syndrome and histone deacetylase inhibitors: \u201cto be or not to be acetylated\u201d? J Biomed Biotechnol. 2011;2011:214143. doi:\n                10.1155/2011/214143\n                \n              .", "journal-title": "J Biomed Biotechnol"}, {"issue": "8", "key": "2_CR175", "first-page": "557", "volume": "10", "author": "R Schneider-Stock", "year": "2007", "unstructured": "Schneider-Stock R, Ocker M. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors. IDrugs. 2007;10(8):557\u201361.", "journal-title": "IDrugs"}, {"issue": "8", "key": "2_CR176", "first-page": "2989", "volume": "33", "author": "A Gnyszka", "year": "2013", "unstructured": "Gnyszka A, Jastrzebski Z, Flis S. DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer. Anticancer Res. 2013;33(8):2989\u201396.", "journal-title": "Anticancer Res"}, {"issue": "1", "key": "2_CR177", "doi-asserted-by": "publisher", "first-page": "103", "DOI": "10.1080/00365520600874198", "volume": "42", "author": "D Neureiter", "year": "2007", "unstructured": "Neureiter D, Zopf S, Leu T, Dietze O, Hauser-Kronberger C, Hahn EG, Herold C, Ocker M. Apoptosis, proliferation and differentiation patterns are influenced by Zebularine and SAHA in pancreatic cancer models. Scand J Gastroenterol. 2007;42(1):103\u201316. doi:\n                10.1080/00365520600874198\n                \n              .", "journal-title": "Scand J Gastroenterol"}, {"issue": "5", "key": "2_CR178", "doi-asserted-by": "publisher", "first-page": "55", "DOI": "10.4331/wjbc.v1.i5.55", "volume": "1", "author": "M Ocker", "year": "2010", "unstructured": "Ocker M. Deacetylase inhibitors\u2014focus on non-histone targets and effects. World J Biol Chem. 2010;1(5):55\u201361. doi:\n                10.4331/wjbc.v1.i5.55\n                \n              .", "journal-title": "World J Biol Chem"}, {"issue": "20", "key": "2_CR179", "doi-asserted-by": "publisher", "first-page": "4670", "DOI": "10.1002/cncr.25414", "volume": "116", "author": "S Fu", "year": "2010", "unstructured": "Fu S, Kurzrock R. Development of curcumin as an epigenetic agent. Cancer. 2010;116(20):4670\u20136. doi:\n                10.1002/cncr.25414\n                \n              .", "journal-title": "Cancer"}, {"issue": "2", "key": "2_CR180", "doi-asserted-by": "publisher", "first-page": "169", "DOI": "10.2174/157340606776056133", "volume": "2", "author": "MG Marcu", "year": "2006", "unstructured": "Marcu MG, Jung YJ, Lee S, Chung EJ, Lee MJ, Trepel J, Neckers L. Curcumin is an inhibitor of p300 histone acetylatransferase. Med Chem. 2006;2(2):169\u201374.", "journal-title": "Med Chem"}, {"issue": "14", "key": "2_CR181", "doi-asserted-by": "publisher", "first-page": "4491", "DOI": "10.1158/1078-0432.CCR-08-0024", "volume": "14", "author": "N Dhillon", "year": "2008", "unstructured": "Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, Kurzrock R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008;14(14):4491\u20139. doi:\n                10.1158/1078-0432.ccr-08-0024\n                \n              .", "journal-title": "Clin Cancer Res"}, {"issue": "11", "key": "2_CR182", "doi-asserted-by": "publisher", "first-page": "765", "DOI": "10.1038/nrg3554", "volume": "14", "author": "C Plass", "year": "2013", "unstructured": "Plass C, Pfister SM, Lindroth AM, Bogatyrova O, Claus R, Lichter P. Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nat Rev Genet. 2013;14(11):765\u201380. doi:\n                10.1038/nrg3554\n                \n              .", "journal-title": "Nat Rev Genet"}, {"issue": "6", "key": "2_CR183", "doi-asserted-by": "publisher", "first-page": "217", "DOI": "10.1016/j.cancergen.2013.05.020", "volume": "206", "author": "Y Xue", "year": "2013", "unstructured": "Xue Y, Abou Tayoun AN, Abo KM, Pipas JM, Gordon SR, Gardner TB, Barth Jr RJ, Suriawinata AA, Tsongalis GJ. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. Cancer Genet. 2013;206(6):217\u201321. doi:\n                10.1016/j.cancergen.2013.05.020\n                \n              .", "journal-title": "Cancer Genet"}, {"issue": "22", "key": "2_CR184", "doi-asserted-by": "publisher", "first-page": "6541", "DOI": "10.1158/0008-5472.CAN-13-1288", "volume": "73", "author": "S Khan", "year": "2013", "unstructured": "Khan S, Ansarullah KD, Jaggi M, Chauhan SC. Targeting microRNAs in pancreatic cancer: microplayers in the big game. Cancer Res. 2013;73(22):6541\u20137. doi:\n                10.1158/0008-5472.can-13-1288\n                \n              .", "journal-title": "Cancer Res"}, {"issue": "10", "key": "2_CR185", "doi-asserted-by": "publisher", "first-page": "1101", "DOI": "10.2174/13894501113149990181", "volume": "14", "author": "P Pai", "year": "2013", "unstructured": "Pai P, Rachagani S, Are C, Batra SK. Prospects of miRNA-based therapy for pancreatic cancer. Curr Drug Targets. 2013;14(10):1101\u20139.", "journal-title": "Curr Drug Targets"}, {"issue": "3", "key": "2_CR186", "first-page": "567", "volume": "31", "author": "S Gahr", "year": "2007", "unstructured": "Gahr S, Ocker M, Ganslmayer M, Zopf S, Okamoto K, Hartl A, Leitner S, Hahn EG, Herold C. The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells. Int J Oncol. 2007;31(3):567\u201376.", "journal-title": "Int J Oncol"}, {"issue": "14", "key": "2_CR187", "first-page": "4158", "volume": "63", "author": "N Sato", "year": "2003", "unstructured": "Sato N, Maitra A, Fukushima N, van Heek NT, Matsubayashi H, Iacobuzio-Donahue CA, Rosty C, Goggins M. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res. 2003;63(14):4158\u201366.", "journal-title": "Cancer Res"}, {"issue": "2", "key": "2_CR188", "doi-asserted-by": "publisher", "first-page": "193", "DOI": "10.1016/S0304-3835(03)00390-2", "volume": "199", "author": "N Ohike", "year": "2003", "unstructured": "Ohike N, Maass N, Mundhenke C, Biallek M, Zhang M, Jonat W, Luttges J, Morohoshi T, Kloppel G, Nagasaki K. Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas. Cancer Lett. 2003;199(2):193\u2013200.", "journal-title": "Cancer Lett"}, {"issue": "4", "key": "2_CR189", "doi-asserted-by": "publisher", "first-page": "321", "DOI": "10.4161/cbt.9.4.10750", "volume": "9", "author": "A Li", "year": "2010", "unstructured": "Li A, Omura N, Hong SM, Goggins M. Pancreatic cancer DNMT1 expression and sensitivity to DNMT1 inhibitors. Cancer Biol Ther. 2010;9(4):321\u20139. doi:\n                10.4161/cbt.9.4.10750\n                \n              .", "journal-title": "Cancer Biol Ther"}, {"issue": "12", "key": "2_CR190", "doi-asserted-by": "publisher", "first-page": "1495", "DOI": "10.1097/00000478-200312000-00001", "volume": "27", "author": "C Rosty", "year": "2003", "unstructured": "Rosty C, Geradts J, Sato N, Wilentz RE, Roberts H, Sohn T, Cameron JL, Yeo CJ, Hruban RH, Goggins M. p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis. Am J Surg Pathol. 2003;27(12):1495\u2013501.", "journal-title": "Am J Surg Pathol"}, {"issue": "3", "key": "2_CR191", "doi-asserted-by": "publisher", "first-page": "293", "DOI": "10.4161/cbt.84", "volume": "1", "author": "M Jansen", "year": "2002", "unstructured": "Jansen M, Fukushima N, Rosty C, Walter K, Altink R, Heek TV, Hruban R, Offerhaus JG, Goggins M. Aberrant methylation of the 5\u2032 CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs. Cancer Biol Ther. 2002;1(3):293\u20136.", "journal-title": "Cancer Biol Ther"}, {"issue": "5", "key": "2_CR192", "doi-asserted-by": "publisher", "first-page": "675", "DOI": "10.1097/MPA.0b013e3181c8b476", "volume": "39", "author": "E Angst", "year": "2010", "unstructured": "Angst E, Dawson DW, Nguyen A, Park J, Go VL, Reber HA, Hines OJ, Eibl G. Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells. Pancreas. 2010;39(5):675\u20139. doi:\n                10.1097/MPA.0b013e3181c8b476\n                \n              .", "journal-title": "Pancreas"}, {"issue": "6", "key": "2_CR193", "doi-asserted-by": "publisher", "first-page": "2136", "DOI": "10.1053/j.gastro.2009.08.065", "volume": "137", "author": "FU Weiss", "year": "2009", "unstructured": "Weiss FU, Marques IJ, Woltering JM, Vlecken DH, Aghdassi A, Partecke LI, Heidecke CD, Lerch MM, Bagowski CP. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology. 2009;137(6):2136\u201345.e1\u20137. doi:\n                10.1053/j.gastro.2009.08.065\n                \n              .", "journal-title": "Gastroenterology"}, {"issue": "7", "key": "2_CR194", "doi-asserted-by": "publisher", "first-page": "2394", "DOI": "10.1245/s10434-012-2252-3", "volume": "19", "author": "K Ohuchida", "year": "2012", "unstructured": "Ohuchida K, Mizumoto K, Lin C, Yamaguchi H, Ohtsuka T, Sato N, Toma H, Nakamura M, Nagai E, Hashizume M, Tanaka M. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. Ann Surg Oncol. 2012;19(7):2394\u2013402. doi:\n                10.1245/s10434-012-2252-3\n                \n              .", "journal-title": "Ann Surg Oncol"}, {"issue": "5", "key": "2_CR195", "doi-asserted-by": "publisher", "first-page": "1067", "DOI": "10.1158/1535-7163.MCT-08-0592", "volume": "8", "author": "T Moriyama", "year": "2009", "unstructured": "Moriyama T, Ohuchida K, Mizumoto K, Yu J, Sato N, Nabae T, Takahata S, Toma H, Nagai E, Tanaka M. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther. 2009;8(5):1067\u201374. doi:\n                10.1158/1535-7163.mct-08-0592\n                \n              .", "journal-title": "Mol Cancer Ther"}, {"issue": "4", "key": "2_CR196", "first-page": "265", "volume": "30", "author": "S Zhang", "year": "2008", "unstructured": "Zhang S, Cai X, Huang F, Zhong W, Yu Z. Effect of trichostatin a on viability and microRNA expression in human pancreatic cancer cell line BxPC-3. Exp Oncol. 2008;30(4):265\u20138.", "journal-title": "Exp Oncol"}, {"issue": "1", "key": "2_CR197", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.1097/MPA.0b013e318221c903", "volume": "41", "author": "JK Park", "year": "2012", "unstructured": "Park JK, Ryu JK, Yoon WJ, Lee SH, Lee GY, Jeong KS, Kim YT, Yoon YB. The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer. Pancreas. 2012;41(1):95\u2013101. doi:\n                10.1097/MPA.0b013e318221c903\n                \n              .", "journal-title": "Pancreas"}, {"issue": "4", "key": "2_CR198", "doi-asserted-by": "publisher", "first-page": "518", "DOI": "10.1016/j.bbrc.2011.02.065", "volume": "406", "author": "JK Park", "year": "2011", "unstructured": "Park JK, Henry JC, Jiang J, Esau C, Gusev Y, Lerner MR, Postier RG, Brackett DJ, Schmittgen TD. miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochem Biophys Res Commun. 2011;406(4):518\u201323. doi:\n                10.1016/j.bbrc.2011.02.065\n                \n              .", "journal-title": "Biochem Biophys Res Commun"}, {"issue": "41", "key": "2_CR199", "doi-asserted-by": "publisher", "first-page": "16170", "DOI": "10.1073/pnas.0703942104", "volume": "104", "author": "M Gironella", "year": "2007", "unstructured": "Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, Chaix A, Fazli L, Motoo Y, Wang Q, Rocchi P, Russo A, Gleave M, Dagorn JC, Iovanna JL, Carrier A, Pebusque MJ, Dusetti NJ. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci U S A. 2007;104(41):16170\u20135. doi:\n                10.1073/pnas.0703942104\n                \n              .", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "1", "key": "2_CR200", "doi-asserted-by": "publisher", "first-page": "114", "DOI": "10.1002/ijc.24695", "volume": "126", "author": "ST Mees", "year": "2010", "unstructured": "Mees ST, Mardin WA, Wendel C, Baeumer N, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J. EP300\u2014a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. Int J Cancer. 2010;126(1):114\u201324. doi:\n                10.1002/ijc.24695\n                \n              .", "journal-title": "Int J Cancer"}, {"issue": "6", "key": "2_CR201", "doi-asserted-by": "publisher", "first-page": "1255", "DOI": "10.1002/jcp.24280", "volume": "228", "author": "S Hamada", "year": "2013", "unstructured": "Hamada S, Satoh K, Miura S, Hirota M, Kanno A, Masamune A, Kikuta K, Kume K, Unno J, Egawa S, Motoi F, Unno M, Shimosegawa T. miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin. J Cell Physiol. 2013;228(6):1255\u201363. doi:\n                10.1002/jcp.24280\n                \n              .", "journal-title": "J Cell Physiol"}, {"issue": "3", "key": "2_CR202", "doi-asserted-by": "publisher", "first-page": "433", "DOI": "10.1016/j.bbrc.2013.06.097", "volume": "437", "author": "T Takikawa", "year": "2013", "unstructured": "Takikawa T, Masamune A, Hamada S, Nakano E, Yoshida N, Shimosegawa T. miR-210 regulates the interaction between pancreatic cancer cells and stellate cells. Biochem Biophys Res Commun. 2013;437(3):433\u20139. doi:\n                10.1016/j.bbrc.2013.06.097\n                \n              .", "journal-title": "Biochem Biophys Res Commun"}, {"issue": "7", "key": "2_CR203", "doi-asserted-by": "publisher", "first-page": "e190", "DOI": "10.1097/MPA.0b013e3181ba82e1", "volume": "38", "author": "JK Park", "year": "2009", "unstructured": "Park JK, Lee EJ, Esau C, Schmittgen TD. Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. Pancreas. 2009;38(7):e190\u20139. doi:\n                10.1097/MPA.0b013e3181ba82e1\n                \n              .", "journal-title": "Pancreas"}, {"issue": "8", "key": "2_CR204", "doi-asserted-by": "publisher", "first-page": "2339", "DOI": "10.1245/s10434-009-0531-4", "volume": "16", "author": "ST Mees", "year": "2009", "unstructured": "Mees ST, Mardin WA, Sielker S, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Ann Surg Oncol. 2009;16(8):2339\u201350. doi:\n                10.1245/s10434-009-0531-4\n                \n              .", "journal-title": "Ann Surg Oncol"}, {"issue": "10", "key": "2_CR205", "doi-asserted-by": "publisher", "first-page": "3229", "DOI": "10.1002/jcb.24200", "volume": "113", "author": "Z Chen", "year": "2012", "unstructured": "Chen Z, Chen LY, Dai HY, Wang P, Gao S, Wang K. miR-301a promotes pancreatic cancer cell proliferation by directly inhibiting Bim expression. J Cell Biochem. 2012;113(10):3229\u201335. doi:\n                10.1002/jcb.24200\n                \n              .", "journal-title": "J Cell Biochem"}, {"issue": "2", "key": "2_CR206", "doi-asserted-by": "publisher", "first-page": "502", "DOI": "10.1038/bjc.2013.320", "volume": "109", "author": "Y Iwagami", "year": "2013", "unstructured": "Iwagami Y, Eguchi H, Nagano H, Akita H, Hama N, Wada H, Kawamoto K, Kobayashi S, Tomokuni A, Tomimaru Y, Mori M, Doki Y. miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1. Br J Cancer. 2013;109(2):502\u201311. doi:\n                10.1038/bjc.2013.320\n                \n              .", "journal-title": "Br J Cancer"}, {"issue": "4", "key": "2_CR207", "doi-asserted-by": "publisher", "first-page": "552", "DOI": "10.1016/j.bbrc.2011.02.086", "volume": "406", "author": "J Hao", "year": "2011", "unstructured": "Hao J, Zhang S, Zhou Y, Liu C, Hu X, Shao C. MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochem Biophys Res Commun. 2011;406(4):552\u20137. doi:\n                10.1016/j.bbrc.2011.02.086\n                \n              .", "journal-title": "Biochem Biophys Res Commun"}, {"issue": "12", "key": "2_CR208", "doi-asserted-by": "publisher", "first-page": "14733", "DOI": "10.3390/molecules171214733", "volume": "17", "author": "R Guo", "year": "2012", "unstructured": "Guo R, Wang Y, Shi WY, Liu B, Hou SQ, Liu L. MicroRNA miR-491-5p targeting both TP53 and Bcl-XL induces cell apoptosis in SW1990 pancreatic cancer cells through mitochondria mediated pathway. Molecules. 2012;17(12):14733\u201347. doi:\n                10.3390/molecules171214733\n                \n              .", "journal-title": "Molecules"}, {"issue": "8", "key": "2_CR209", "doi-asserted-by": "publisher", "first-page": "831", "DOI": "10.1089/hum.2008.134", "volume": "20", "author": "J Torrisani", "year": "2009", "unstructured": "Torrisani J, Bournet B, du Rieu MC, Bouisson M, Souque A, Escourrou J, Buscail L, Cordelier P. let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Hum Gene Ther. 2009;20(8):831\u201344. doi:\n                10.1089/hum.2008.134\n                \n              .", "journal-title": "Hum Gene Ther"}, {"issue": "1", "key": "2_CR210", "doi-asserted-by": "publisher", "first-page": "5", "DOI": "10.1016/j.ijrobp.2009.08.028", "volume": "76", "author": "JS Oh", "year": "2010", "unstructured": "Oh JS, Kim JJ, Byun JY, Kim IA. Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras. Int J Radiat Oncol Biol Phys. 2010;76(1):5\u20138. doi:\n                10.1016/j.ijrobp.2009.08.028\n                \n              .", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "3", "key": "2_CR211", "doi-asserted-by": "publisher", "first-page": "464", "DOI": "10.1158/1535-7163.MCT-07-2272", "volume": "7", "author": "M Sun", "year": "2008", "unstructured": "Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R. Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther. 2008;7(3):464\u201373. doi:\n                10.1158/1535-7163.mct-07-2272\n                \n              .", "journal-title": "Mol Cancer Ther"}, {"issue": "2", "key": "2_CR212", "doi-asserted-by": "publisher", "first-page": "187", "DOI": "10.1016/j.diabres.2011.12.028", "volume": "96", "author": "W Li", "year": "2012", "unstructured": "Li W, Yuan Y, Huang L, Qiao M, Zhang Y. Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells. Diabetes Res Clin Pract. 2012;96(2):187\u201395. doi:\n                10.1016/j.diabres.2011.12.028\n                \n              .", "journal-title": "Diabetes Res Clin Pract"}, {"issue": "8", "key": "2_CR213", "doi-asserted-by": "publisher", "DOI": "10.1371/journal.pone.0006816", "volume": "4", "author": "Q Ji", "year": "2009", "unstructured": "Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L, Xiang D, Desano JT, Bommer GT, Fan D, Fearon ER, Lawrence TS, Xu L. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One. 2009;4(8), e6816. doi:\n                10.1371/journal.pone.0006816\n                \n              .", "journal-title": "PLoS One"}, {"issue": "9", "key": "2_CR214", "doi-asserted-by": "publisher", "first-page": "2265", "DOI": "10.1016/j.biomaterials.2012.12.016", "volume": "34", "author": "QL Hu", "year": "2013", "unstructured": "Hu QL, Jiang QY, Jin X, Shen J, Wang K, Li YB, Xu FJ, Tang GP, Li ZH. Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model. Biomaterials. 2013;34(9):2265\u201376. doi:\n                10.1016/j.biomaterials.2012.12.016\n                \n              .", "journal-title": "Biomaterials"}, {"issue": "14", "key": "2_CR215", "doi-asserted-by": "publisher", "first-page": "1750", "DOI": "10.2174/138945012804545597", "volume": "13", "author": "J Xia", "year": "2012", "unstructured": "Xia J, Duan Q, Ahmad A, Bao B, Banerjee S, Shi Y, Ma J, Geng J, Chen Z, Rahman KM, Miele L, Sarkar FH, Wang Z. Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. Curr Drug Targets. 2012;13(14):1750\u20136.", "journal-title": "Curr Drug Targets"}, {"issue": "4", "key": "2_CR216", "doi-asserted-by": "publisher", "first-page": "467", "DOI": "10.2174/1566524011313040001", "volume": "13", "author": "C Liu", "year": "2013", "unstructured": "Liu C, Cheng H, Shi S, Cui X, Yang J, Chen L, Cen P, Cai X, Lu Y, Wu C, Yao W, Qin Y, Liu L, Long J, Xu J, Li M, Yu X. MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3. Curr Mol Med. 2013;13(4):467\u201378.", "journal-title": "Curr Mol Med"}, {"issue": "3", "key": "2_CR217", "doi-asserted-by": "publisher", "first-page": "293", "DOI": "10.1159/000186051", "volume": "9", "author": "KH Lee", "year": "2009", "unstructured": "Lee KH, Lotterman C, Karikari C, Omura N, Feldmann G, Habbe N, Goggins MG, Mendell JT, Maitra A. Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology. 2009;9(3):293\u2013301. doi:\n                10.1159/000186051\n                \n              .", "journal-title": "Pancreatology"}, {"issue": "1", "key": "2_CR218", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1158/1541-7786.MCR-11-0272", "volume": "10", "author": "S Hamada", "year": "2012", "unstructured": "Hamada S, Satoh K, Fujibuchi W, Hirota M, Kanno A, Unno J, Masamune A, Kikuta K, Kume K, Shimosegawa T. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9. Mol Cancer Res. 2012;10(1):3\u201310. doi:\n                10.1158/1541-7786.mcr-11-0272\n                \n              .", "journal-title": "Mol Cancer Res"}, {"issue": "1", "key": "2_CR219", "doi-asserted-by": "publisher", "first-page": "6", "DOI": "10.1016/j.bbrc.2013.08.042", "volume": "439", "author": "H Pham", "year": "2013", "unstructured": "Pham H, Rodriguez CE, Donald GW, Hertzer KM, Jung XS, Chang HH, Moro A, Reber HA, Hines OJ, Eibl G. miR-143 decreases COX-2 mRNA stability and expression in pancreatic cancer cells. Biochem Biophys Res Commun. 2013;439(1):6\u201311. doi:\n                10.1016/j.bbrc.2013.08.042\n                \n              .", "journal-title": "Biochem Biophys Res Commun"}, {"issue": "6", "key": "2_CR220", "doi-asserted-by": "publisher", "first-page": "1863", "DOI": "10.1007/s13277-012-0446-8", "volume": "33", "author": "Y Hu", "year": "2012", "unstructured": "Hu Y, Ou Y, Wu K, Chen Y, Sun W. miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway. Tumour Biol. 2012;33(6):1863\u201370. doi:\n                10.1007/s13277-012-0446-8\n                \n              .", "journal-title": "Tumour Biol"}, {"issue": "10", "key": "2_CR221", "doi-asserted-by": "publisher", "first-page": "1472", "DOI": "10.1038/labinvest.2011.99", "volume": "91", "author": "ST Liffers", "year": "2011", "unstructured": "Liffers ST, Munding JB, Vogt M, Kuhlmann JD, Verdoodt B, Nambiar S, Maghnouj A, Mirmohammadsadegh A, Hahn SA, Tannapfel A. MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. Lab Invest. 2011;91(10):1472\u20139. doi:\n                10.1038/labinvest.2011.99\n                \n              .", "journal-title": "Lab Invest"}, {"issue": "1", "key": "2_CR222", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1158/1535-7163.MCT-12-0534-T", "volume": "12", "author": "G Zhao", "year": "2013", "unstructured": "Zhao G, Zhang JG, Liu Y, Qin Q, Wang B, Tian K, Liu L, Li X, Niu Y, Deng SC, Wang CY. miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKalpha1. Mol Cancer Ther. 2013;12(1):83\u201393. doi:\n                10.1158/1535-7163.mct-12-0534-t\n                \n              .", "journal-title": "Mol Cancer Ther"}, {"issue": "12", "key": "2_CR223", "doi-asserted-by": "publisher", "first-page": "1832", "DOI": "10.1093/carcin/bgr223", "volume": "32", "author": "SK Srivastava", "year": "2011", "unstructured": "Srivastava SK, Bhardwaj A, Singh S, Arora S, Wang B, Grizzle WE, Singh AP. MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis. 2011;32(12):1832\u20139. doi:\n                10.1093/carcin/bgr223\n                \n              .", "journal-title": "Carcinogenesis"}, {"issue": "16", "key": "2_CR224", "doi-asserted-by": "publisher", "first-page": "6704", "DOI": "10.1158/0008-5472.CAN-09-1298", "volume": "69", "author": "Y Li", "year": "2009", "unstructured": "Li Y, VandenBoom 2nd TG, Kong D, Wang Z, Ali S, Philip PA, Sarkar FH. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res. 2009;69(16):6704\u201312. doi:\n                10.1158/0008-5472.can-09-1298\n                \n              .", "journal-title": "Cancer Res"}, {"issue": "5-6", "key": "2_CR225", "doi-asserted-by": "publisher", "first-page": "197", "DOI": "10.3727/096504013X13589503482734", "volume": "20", "author": "J Zhou", "year": "2012", "unstructured": "Zhou J, Song S, Cen J, Zhu D, Li D, Zhang Z. MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro. Oncol Res. 2012;20(5-6):197\u2013203.", "journal-title": "Oncol Res"}, {"issue": "24", "key": "2_CR226", "doi-asserted-by": "publisher", "first-page": "3806", "DOI": "10.1038/sj.onc.1206582", "volume": "22", "author": "R Dammann", "year": "2003", "unstructured": "Dammann R, Schagdarsurengin U, Liu L, Otto N, Gimm O, Dralle H, Boehm BO, Pfeifer GP, Hoang-Vu C. Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma. Oncogene. 2003;22(24):3806\u201312. doi:\n                10.1038/sj.onc.1206582\n                \n              .", "journal-title": "Oncogene"}, {"issue": "3", "key": "2_CR227", "doi-asserted-by": "publisher", "first-page": "279", "DOI": "10.1038/onc.2012.595", "volume": "33", "author": "KL Thu", "year": "2014", "unstructured": "Thu KL, Radulovich N, Becker-Santos DD, Pikor LA, Pusic A, Lockwood WW, Lam WL, Tsao MS. SOX15 is a candidate tumor suppressor in pancreatic cancer with a potential role in Wnt/beta-catenin signaling. Oncogene. 2014;33(3):279\u201388. doi:\n                10.1038/onc.2012.595\n                \n              .", "journal-title": "Oncogene"}, {"key": "2_CR228", "doi-asserted-by": "publisher", "first-page": "397", "DOI": "10.1186/1471-2407-12-397", "volume": "12", "author": "M Waraya", "year": "2012", "unstructured": "Waraya M, Yamashita K, Katoh H, Ooki A, Kawamata H, Nishimiya H, Nakamura K, Ema A, Watanabe M. Cancer specific promoter CpG Islands hypermethylation of HOP homeobox (HOPX) gene and its potential tumor suppressive role in pancreatic carcinogenesis. BMC Cancer. 2012;12:397. doi:\n                10.1186/1471-2407-12-397\n                \n              .", "journal-title": "BMC Cancer"}, {"issue": "2", "key": "2_CR229", "doi-asserted-by": "publisher", "first-page": "423", "DOI": "10.1016/j.ajpath.2012.04.025", "volume": "181", "author": "VH Chang", "year": "2012", "unstructured": "Chang VH, Chu PY, Peng SL, Mao TL, Shan YS, Hsu CF, Lin CY, Tsai KK, Yu WC, Ch\u2032ang HJ. Kruppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma. Am J Pathol. 2012;181(2):423\u201330. doi:\n                10.1016/j.ajpath.2012.04.025\n                \n              .", "journal-title": "Am J Pathol"}, {"issue": "2", "key": "2_CR230", "doi-asserted-by": "publisher", "first-page": "970", "DOI": "10.1007/s12032-011-9968-y", "volume": "29", "author": "M Li", "year": "2012", "unstructured": "Li M, Zhao ZW. Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer. Med Oncol. 2012;29(2):970\u20136. doi:\n                10.1007/s12032-011-9968-y\n                \n              .", "journal-title": "Med Oncol"}, {"issue": "3", "key": "2_CR231", "doi-asserted-by": "publisher", "first-page": "313", "DOI": "10.1007/s00428-010-1030-5", "volume": "458", "author": "M Vogt", "year": "2011", "unstructured": "Vogt M, Munding J, Gruner M, Liffers ST, Verdoodt B, Hauk J, Steinstraesser L, Tannapfel A, Hermeking H. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch. 2011;458(3):313\u201322. doi:\n                10.1007/s00428-010-1030-5\n                \n              .", "journal-title": "Virchows Arch"}, {"key": "2_CR232", "doi-asserted-by": "publisher", "first-page": "28", "DOI": "10.1186/1756-9966-29-28", "volume": "29", "author": "J Gao", "year": "2010", "unstructured": "Gao J, Song J, Huang H, Li Z, Du Y, Cao J, Li M, Lv S, Lin H, Gong Y. Methylation of the SPARC gene promoter and its clinical implication in pancreatic cancer. J Exp Clin Cancer Res. 2010;29:28. doi:\n                10.1186/1756-9966-29-28\n                \n              .", "journal-title": "J Exp Clin Cancer Res"}, {"issue": "12", "key": "2_CR233", "doi-asserted-by": "publisher", "first-page": "3536", "DOI": "10.1158/1055-9965.EPI-08-0630", "volume": "17", "author": "K Brune", "year": "2008", "unstructured": "Brune K, Hong SM, Li A, Yachida S, Abe T, Griffith M, Yang D, Omura N, Eshleman J, Canto M, Schulick R, Klein AP, Hruban RH, Iacobuzio-Donohue C, Goggins M. Genetic and epigenetic alterations of familial pancreatic cancers. Cancer Epidemiol Biomarkers Prev. 2008;17(12):3536\u201342. doi:\n                10.1158/1055-9965.epi-08-0630\n                \n              .", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"issue": "21", "key": "2_CR234", "doi-asserted-by": "publisher", "first-page": "3421", "DOI": "10.3748/wjg.14.3421", "volume": "14", "author": "XM Bu", "year": "2008", "unstructured": "Bu XM, Zhao CH, Zhang N, Gao F, Lin S, Dai XW. Hypermethylation and aberrant expression of secreted frizzled-related protein genes in pancreatic cancer. World J Gastroenterol. 2008;14(21):3421\u20134.", "journal-title": "World J Gastroenterol"}, {"issue": "3", "key": "2_CR235", "doi-asserted-by": "publisher", "first-page": "238", "DOI": "10.1038/modpathol.3800991", "volume": "21", "author": "N Sato", "year": "2008", "unstructured": "Sato N, Fukushima N, Hruban RH, Goggins M. CpG island methylation profile of pancreatic intraepithelial neoplasia. Mod Pathol. 2008;21(3):238\u201344. doi:\n                10.1038/modpathol.3800991\n                \n              .", "journal-title": "Mod Pathol"}, {"issue": "10", "key": "2_CR236", "doi-asserted-by": "publisher", "first-page": "2608", "DOI": "10.1007/s10620-012-2202-8", "volume": "57", "author": "L Zhang", "year": "2012", "unstructured": "Zhang L, Gao J, Li Z, Gong Y. Neuronal pentraxin II (NPTX2) is frequently down-regulated by promoter hypermethylation in pancreatic cancers. Dig Dis Sci. 2012;57(10):2608\u201314. doi:\n                10.1007/s10620-012-2202-8\n                \n              .", "journal-title": "Dig Dis Sci"}, {"issue": "5", "key": "2_CR237", "doi-asserted-by": "publisher", "first-page": "2115", "DOI": "10.1158/0008-5472.CAN-09-2979", "volume": "70", "author": "Y Song", "year": "2010", "unstructured": "Song Y, Washington MK, Crawford HC. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer. Cancer Res. 2010;70(5):2115\u201325. doi:\n                10.1158/0008-5472.can-09-2979\n                \n              .", "journal-title": "Cancer Res"}, {"issue": "10", "key": "2_CR238", "doi-asserted-by": "publisher", "first-page": "2056", "DOI": "10.1038/bjc.2013.200", "volume": "108", "author": "M Khursheed", "year": "2013", "unstructured": "Khursheed M, Kolla JN, Kotapalli V, Gupta N, Gowrishankar S, Uppin SG, Sastry RA, Koganti S, Sundaram C, Pollack JR, Bashyam MD. ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines. Br J Cancer. 2013;108(10):2056\u201362. doi:\n                10.1038/bjc.2013.200\n                \n              .", "journal-title": "Br J Cancer"}, {"issue": "8", "key": "2_CR239", "doi-asserted-by": "publisher", "first-page": "4903", "DOI": "10.1007/s11033-010-0632-y", "volume": "38", "author": "L Zhang", "year": "2011", "unstructured": "Zhang L, Gao J, Li L, Li Z, Du Y, Gong Y. The neuronal pentraxin II gene (NPTX2) inhibit proliferation and invasion of pancreatic cancer cells in vitro. Mol Biol Rep. 2011;38(8):4903\u201311. doi:\n                10.1007/s11033-010-0632-y\n                \n              .", "journal-title": "Mol Biol Rep"}, {"issue": "33", "key": "2_CR240", "doi-asserted-by": "publisher", "first-page": "3810", "DOI": "10.3748/wjg.v17.i33.3810", "volume": "17", "author": "YM Gu", "year": "2011", "unstructured": "Gu YM, Ma YH, Zhao WG, Chen J. Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro. World J Gastroenterol. 2011;17(33):3810\u20137. doi:\n                10.3748/wjg.v17.i33.3810\n                \n              .", "journal-title": "World J Gastroenterol"}, {"issue": "7", "key": "2_CR241", "doi-asserted-by": "publisher", "first-page": "1761", "DOI": "10.1002/jcb.23095", "volume": "112", "author": "T Ito", "year": "2011", "unstructured": "Ito T, Kojima T, Yamaguchi H, Kyuno D, Kimura Y, Imamura M, Takasawa A, Murata M, Tanaka S, Hirata K, Sawada N. Transcriptional regulation of claudin-18 via specific protein kinase C signaling pathways and modification of DNA methylation in human pancreatic cancer cells. J Cell Biochem. 2011;112(7):1761\u201372. doi:\n                10.1002/jcb.23095\n                \n              .", "journal-title": "J Cell Biochem"}, {"issue": "1", "key": "2_CR242", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.1016/S1499-3872(11)60014-3", "volume": "10", "author": "HH Cai", "year": "2011", "unstructured": "Cai HH, Sun YM, Miao Y, Gao WT, Peng Q, Yao J, Zhao HL. Aberrant methylation frequency of TNFRSF10C promoter in pancreatic cancer cell lines. Hepatobiliary Pancreat Dis Int. 2011;10(1):95\u2013100.", "journal-title": "Hepatobiliary Pancreat Dis Int"}, {"issue": "3", "key": "2_CR243", "doi-asserted-by": "publisher", "first-page": "175", "DOI": "10.1097/MAJ.0b013e31827b94b6", "volume": "346", "author": "F Yao", "year": "2013", "unstructured": "Yao F, Sun M, Dong M, Jing F, Chen B, Xu H, Wang S. NPTX2 hypermethylation in pure pancreatic juice predicts pancreatic neoplasms. Am J Med Sci. 2013;346(3):175\u201380. doi:\n                10.1097/MAJ.0b013e31827b94b6\n                \n              .", "journal-title": "Am J Med Sci"}, {"issue": "11", "key": "2_CR244", "doi-asserted-by": "publisher", "first-page": "1718", "DOI": "10.3748/wjg.v19.i11.1718", "volume": "19", "author": "N Kato", "year": "2013", "unstructured": "Kato N, Yamamoto H, Adachi Y, Ohashi H, Taniguchi H, Suzuki H, Nakazawa M, Kaneto H, Sasaki S, Imai K, Shinomura Y. Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids. World J Gastroenterol. 2013;19(11):1718\u201327. doi:\n                10.3748/wjg.v19.i11.1718\n                \n              .", "journal-title": "World J Gastroenterol"}, {"issue": "3", "key": "2_CR245", "doi-asserted-by": "publisher", "first-page": "700", "DOI": "10.1158/1078-0432.CCR-11-1718", "volume": "18", "author": "SM Hong", "year": "2012", "unstructured": "Hong SM, Omura N, Vincent A, Li A, Knight S, Yu J, Hruban RH, Goggins M. Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res. 2012;18(3):700\u201312. doi:\n                10.1158/1078-0432.ccr-11-1718\n                \n              .", "journal-title": "Clin Cancer Res"}, {"issue": "Suppl 1", "key": "2_CR246", "doi-asserted-by": "publisher", "first-page": "S175", "DOI": "10.1007/s12032-010-9683-0", "volume": "28", "author": "Y Zhu", "year": "2011", "unstructured": "Zhu Y, Zhang JJ, Zhu R, Zhu Y, Liang WB, Gao WT, Yu JB, Xu ZK, Miao Y. The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma. Med Oncol. 2011;28 Suppl 1:S175\u201384. doi:\n                10.1007/s12032-010-9683-0\n                \n              .", "journal-title": "Med Oncol"}, {"issue": "1", "key": "2_CR247", "doi-asserted-by": "publisher", "first-page": "265", "DOI": "10.3892/or.2011.1475", "volume": "27", "author": "M Chen", "year": "2012", "unstructured": "Chen M, Xue X, Wang F, An Y, Tang D, Xu Y, Wang H, Yuan Z, Gao W, Wei J, Zhang J, Miao Y. Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer. Oncol Rep. 2012;27(1):265\u20139. doi:\n                10.3892/or.2011.1475\n                \n              .", "journal-title": "Oncol Rep"}], "container-title": ["Epigenetic Advancements in Cancer"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-24951-3_2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 2]], "date-time": "2019-06-02T03:18:54Z", "timestamp": 1559445534000}, "score": 25.494429, "issued": {"date-parts": [[2016]]}, "ISBN": ["9783319249490", "9783319249513"], "references-count": 247, "URL": "http://dx.doi.org/10.1007/978-3-319-24951-3_2", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T14:25:21Z", "timestamp": 1574864721831}, "reference-count": 130, "publisher": "Elsevier", "isbn-type": [{"value": "9780128095522", "type": "print"}], "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2018, 1, 1]], "date-time": "2018-01-01T00:00:00Z", "timestamp": 1514764800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018]]}, "DOI": "10.1016/b978-0-12-809552-2.00007-3", "type": "book-chapter", "created": {"date-parts": [[2017, 11, 28]], "date-time": "2017-11-28T23:49:24Z", "timestamp": 1511912964000}, "page": "169-193", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Epigenetic Modulations in Ovarian Cancer"], "prefix": "10.1016", "author": [{"given": "Shriti", "family": "Singh", "sequence": "first", "affiliation": []}, {"given": "Manoj K.", "family": "Mishra", "sequence": "additional", "affiliation": []}, {"given": "Rajesh", "family": "Singh", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Epigenetic Mechanisms in Cancer"], "link": [{"URL": "https://api.elsevier.com/content/article/PII:B9780128095522000073?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:B9780128095522000073?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 8, 25]], "date-time": "2018-08-25T18:36:09Z", "timestamp": 1535222169000}, "score": 25.494429, "issued": {"date-parts": [[2018]]}, "ISBN": ["9780128095522"], "references-count": 130, "URL": "http://dx.doi.org/10.1016/b978-0-12-809552-2.00007-3"}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T18:51:18Z", "timestamp": 1575226278665}, "reference-count": 0, "publisher": "American Thoracic Society", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012, 5]]}, "DOI": "10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a3475", "type": "proceedings-article", "created": {"date-parts": [[2013, 5, 23]], "date-time": "2013-05-23T13:00:24Z", "timestamp": 1369314024000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Role Of Histone Lysine Methyltransferase G9a In Cell Proliferation, Contractility, And DNA Methylation In Fetal Pulmonary Arterial Smooth Muscle Cells"], "prefix": "10.1164", "author": [{"given": "Qiwei", "family": "Yang", "sequence": "first", "affiliation": []}, {"given": "Ziyan", "family": "Lu", "sequence": "additional", "affiliation": []}, {"given": "Dev", "family": "Singh", "sequence": "additional", "affiliation": []}, {"given": "J U.", "family": "Raj", "sequence": "additional", "affiliation": []}], "member": "19", "event": {"name": "American Thoracic Society 2012 International Conference, May 18-23, 2012 \u2022 San Francisco, California"}, "container-title": ["B65. EPIGENETIC REGULATION OF LUNG CELL FUNCTION"], "deposited": {"date-parts": [[2013, 5, 23]], "date-time": "2013-05-23T13:00:26Z", "timestamp": 1369314026000}, "score": 25.37508, "issued": {"date-parts": [[2012, 5]]}, "references-count": 0, "alternative-id": ["10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A3475", "10.1164/ajrccm-conference.2012.B065"], "URL": "http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a3475"}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T01:01:00Z", "timestamp": 1574298060055}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 5, 1]], "date-time": "2007-05-01T00:00:00Z", "timestamp": 1177977600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia Research"], "published-print": {"date-parts": [[2007, 5]]}, "DOI": "10.1016/s0145-2126(07)70011-5", "type": "journal-article", "created": {"date-parts": [[2007, 6, 7]], "date-time": "2007-06-07T19:36:40Z", "timestamp": 1181245000000}, "page": "S6-S7", "source": "Crossref", "is-referenced-by-count": 0, "title": ["10 DNA methyltransferase inhibition in the therapy of myelodysplastic syndromes"], "prefix": "10.1016", "volume": "31", "author": [{"given": "V.", "family": "Santini", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Leukemia Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0145212607700115?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0145212607700115?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 6]], "date-time": "2019-01-06T20:57:56Z", "timestamp": 1546808276000}, "score": 24.91976, "issued": {"date-parts": [[2007, 5]]}, "references-count": 0, "alternative-id": ["S0145212607700115"], "URL": "http://dx.doi.org/10.1016/s0145-2126(07)70011-5", "ISSN": ["0145-2126"], "issn-type": [{"value": "0145-2126", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T15:21:11Z", "timestamp": 1574868071152}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2017, 11, 15]]}, "DOI": "10.1158/1538-7445.newfront17-ia13", "type": "proceedings-article", "created": {"date-parts": [[2017, 12, 1]], "date-time": "2017-12-01T14:38:08Z", "timestamp": 1512139088000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract IA13: Combination of DNA methyltransferase and PARP inhibitors as a novel therapy strategy for multiple cancers: Key data in AML and triple negative breast cancer"], "prefix": "10.1158", "author": [{"given": "Nidal", "family": "Muvarak", "sequence": "first", "affiliation": []}, {"given": "Khadiza", "family": "Chowdhury", "sequence": "additional", "affiliation": []}, {"given": "Carine", "family": "Robert", "sequence": "additional", "affiliation": []}, {"given": "Xia", "family": "Limin", "sequence": "additional", "affiliation": []}, {"given": "Eun Yong", "family": "Choi", "sequence": "additional", "affiliation": []}, {"given": "Yi", "family": "Cai", "sequence": "additional", "affiliation": []}, {"given": "Marina", "family": "Bellani", "sequence": "additional", "affiliation": []}, {"given": "Michael", "family": "Seidman", "sequence": "additional", "affiliation": []}, {"given": "Maria R.", "family": "Baer", "sequence": "additional", "affiliation": []}, {"given": "Rena", "family": "Lapidus", "sequence": "additional", "affiliation": []}, {"given": "Stephen B.", "family": "Baylin", "sequence": "additional", "affiliation": []}, {"given": "Feyruz V.", "family": "Rassool", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2017, 11, 14]]}, "event": {"name": "Abstracts: AACR International Conference: New Frontiers in Cancer Research; January 18-22, 2017; Cape Town, South Africa"}, "container-title": ["DNA Repair"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.NEWFRONT17-IA13", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T17:58:37Z", "timestamp": 1558202317000}, "score": 24.87889, "issued": {"date-parts": [[2017, 11, 14]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.NEWFRONT17-IA13"], "URL": "http://dx.doi.org/10.1158/1538-7445.newfront17-ia13"}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T09:39:00Z", "timestamp": 1575106740175}, "publisher-location": "New Jersey", "reference-count": 0, "publisher": "Humana Press", "isbn-type": [{"value": "1592594018", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1385/1-59259-401-8:253", "type": "book-chapter", "created": {"date-parts": [[2003, 11, 18]], "date-time": "2003-11-18T22:59:38Z", "timestamp": 1069196378000}, "page": "253-276", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Cell Cycle Regulators as Targets of Anticancer Therapy"], "prefix": "10.1385", "author": [{"given": "Mikhail V.", "family": "Blagosklonny", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["Cell Cycle Inhibitors in Cancer Therapy"], "deposited": {"date-parts": [[2013, 12, 16]], "date-time": "2013-12-16T23:08:32Z", "timestamp": 1387235312000}, "score": 23.944057, "issued": {"date-parts": [[null]]}, "ISBN": ["1592594018"], "references-count": 0, "URL": "http://dx.doi.org/10.1385/1-59259-401-8:253"}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T03:45:30Z", "timestamp": 1574307930666}, "reference-count": 31, "publisher": "Pleiades Publishing Ltd", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2009, 6, 1]], "date-time": "2009-06-01T00:00:00Z", "timestamp": 1243814400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mol Biol"], "published-print": {"date-parts": [[2009, 6]]}, "DOI": "10.1134/s0026893309030108", "type": "journal-article", "created": {"date-parts": [[2009, 6, 22]], "date-time": "2009-06-22T04:03:31Z", "timestamp": 1245643411000}, "page": "418-425", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Design of oligonucleotide inhibitors for human DNA methyltransferase 1"], "prefix": "10.1134", "volume": "43", "author": [{"given": "A. A.", "family": "Evdokimov", "sequence": "first", "affiliation": []}, {"given": "V. V.", "family": "Zinoviev", "sequence": "additional", "affiliation": []}, {"given": "V. V.", "family": "Kuznetsov", "sequence": "additional", "affiliation": []}, {"given": "N. A.", "family": "Netesova", "sequence": "additional", "affiliation": []}, {"given": "E. G.", "family": "Malygin", "sequence": "additional", "affiliation": []}], "member": "137", "published-online": {"date-parts": [[2009, 6, 23]]}, "reference": [{"key": "3010_CR1", "doi-asserted-by": "crossref", "first-page": "3139", "DOI": "10.1038/sj.onc.1204341", "volume": "20", "author": "K.D. Robertson", "year": "2001", "unstructured": "Robertson K.D. 2001. DNA methylation, methyltransferases, and cancer. Oncogene. 20, 3139\u20133155.", "journal-title": "Oncogene"}, {"key": "3010_CR2", "first-page": "111", "volume": "4", "author": "K.L. Novik", "year": "2002", "unstructured": "Novik K.L., Nimmrich I., Genc B., Maier S., Piepenbrock C., Olek A., Beck S. 2002. Epigenomics: genomewide study of methylation phenomena. Curr. Issues Mol. Biol. 4, 111\u2013128.", "journal-title": "Curr. Issues Mol. Biol."}, {"key": "3010_CR3", "doi-asserted-by": "crossref", "first-page": "2571", "DOI": "10.1007/s00018-004-4201-1", "volume": "61", "author": "A. Hermann", "year": "2004", "unstructured": "Hermann A., Gowher H., Jeltsch A. 2004. Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol. Life Sci. 61, 2571\u20132587.", "journal-title": "Cell Mol. Life Sci."}, {"key": "3010_CR4", "doi-asserted-by": "crossref", "first-page": "18605", "DOI": "10.1074/jbc.M100404200", "volume": "276", "author": "A. Bacolla", "year": "2001", "unstructured": "Bacolla A., Pradhan S., Larson J.E., Roberts R.J., Wells R.D. 2001. Recombinant human DNA (cytosine-5) methyltransferase: 3. Allosteric control, reaction order, and influence of plasmid topology and triplet repeat length on methylation of the fragile X CGG.CCG sequence. J. Biol. Chem. 276, 18605\u201318613.", "journal-title": "J. Biol. Chem."}, {"key": "3010_CR5", "doi-asserted-by": "crossref", "first-page": "14977", "DOI": "10.1021/bi050988f", "volume": "44", "author": "Z.M. Svedruzic", "year": "2005", "unstructured": "Svedruzic Z.M., Reich N.O. 2005. Mechanism of allosteric regulation of Dnmt1\u2019s processivity. Biochemistry. 44, 14977\u201314988.", "journal-title": "Biochemistry"}, {"key": "3010_CR6", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1023/A:1010249510906", "volume": "66", "author": "A.V. Lichtenstein", "year": "2001", "unstructured": "Lichtenstein A.V., Kisseljova N.P. 2001. DNA methylation and carcinogenesis. Biochemistry (Moscow). 66, 235\u2013255.", "journal-title": "Biochemistry (Moscow)"}, {"key": "3010_CR7", "doi-asserted-by": "crossref", "first-page": "743", "DOI": "10.1007/s10541-005-0179-z", "volume": "70", "author": "N.P. Kisseljova", "year": "2005", "unstructured": "Kisseljova N.P., Kisseljov F.L. 2005. DNA demethylation and carcinogenesis. Biochemistry (Moscow). 70, 743\u2013752.", "journal-title": "Biochemistry (Moscow)"}, {"key": "3010_CR8", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1016/j.molonc.2007.01.004", "volume": "1", "author": "Z. Herceg", "year": "2007", "unstructured": "Herceg Z., Hainaut P. 2007. Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis. Molec. Oncol. 1, 26\u201341.", "journal-title": "Molec. Oncol."}, {"key": "3010_CR9", "doi-asserted-by": "crossref", "first-page": "14389", "DOI": "10.1074/jbc.270.24.14389", "volume": "270", "author": "V.G. Kossykh", "year": "1995", "unstructured": "Kossykh V.G., Schlagman S.L., Hattman S.M. 1995. Phage T4 DNA [N6-adenine]-methyltransferase: Overexpression, purification and characterization. J. Biol. Chem. 270, 14389\u201314393.", "journal-title": "J. Biol. Chem."}, {"key": "3010_CR10", "author": "B.I. Kurganov", "year": "1978", "unstructured": "Kurganov B.I. 1978. Allostericheskie fermenty (Allosteric Enzymes). 1978. Moscow: Nauka.", "volume-title": "Allostericheskie fermenty"}, {"key": "3010_CR11", "doi-asserted-by": "crossref", "first-page": "1584", "DOI": "10.1093/nar/23.9.1584", "volume": "23", "author": "A. Laayoun", "year": "1995", "unstructured": "Laayoun A., Smith S.S. 1995. Methylation of slipped duplexes, snapbacks and cruciforms by human DNA(cytosine-5)methyltransferase. Nucleic Acids Res. 23, 1584\u20131589.", "journal-title": "Nucleic Acids Res."}, {"key": "3010_CR12", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1006/jmbi.1998.1761", "volume": "279", "author": "J. Flynn", "year": "1998", "unstructured": "Flynn J., Azzam R., Reich N.O. 1998. DNA binding discrimination of the murine DNA cytosine-C5 methyltransferase. J. Mol. Biol. 279, 101\u2013116.", "journal-title": "J. Mol. Biol."}, {"key": "3010_CR13", "doi-asserted-by": "crossref", "first-page": "8238", "DOI": "10.1074/jbc.M209839200", "volume": "278", "author": "J. Flynn", "year": "2003", "unstructured": "Flynn J., Fang J.Y., Mikovits J.A., Reich N.O. 2003. A potent cell-active allosteric inhibitor of murine DNA cytosine C5 methyltransferase. J. Biol. Chem. 278, 8238\u20138243.", "journal-title": "J. Biol. Chem."}, {"key": "3010_CR14", "doi-asserted-by": "crossref", "first-page": "7347", "DOI": "10.1073/pnas.92.16.7347", "volume": "92", "author": "J.K. Christman", "year": "1995", "unstructured": "Christman J.K., Sheikhnejad G., Marasco C.J., Sufrin J.R. 1995. 5-Methyl-2\u2032-deoxycytidine in single-stranded DNA can act in cis to signal de novo DNA methylation. Proc. Natl. Acad. Sci USA. 92, 7347\u20137351.", "journal-title": "Proc. Natl. Acad. Sci USA."}, {"key": "3010_CR15", "doi-asserted-by": "crossref", "first-page": "4594", "DOI": "10.1074/jbc.274.8.4594", "volume": "274", "author": "P. Bigey", "year": "1999", "unstructured": "Bigey P., Knox J.D., Croteau S., Bhattacharya S.K., Theberge J., Szyf M. 1999. Modified oligonucleotides as bona fide antagonists of proteins interacting with DNA. J. Biol. Chem. 274, 4594\u20134606.", "journal-title": "J. Biol. Chem."}, {"key": "3010_CR16", "doi-asserted-by": "crossref", "first-page": "2021", "DOI": "10.1006/jmbi.1998.2426", "volume": "285", "author": "G. Sheikhnejad", "year": "1999", "unstructured": "Sheikhnejad G., Brank A., Christman J.K., Goddard A., Alvarez E., Ford H., Jr., Marquez V.E., Marasco C.J., Sufrin J.R., O\u2019Gara M., Cheng X. 1999. Mechanism of inhibition of DNA (cytosine C5)-methyltransferases by oligodeoxyribonucleotides containing 5,6-dihydro-5-azacytosine. J. Mol. Biol. 285, 2021\u20132034.", "journal-title": "J. Mol. Biol."}, {"key": "3010_CR17", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1006/jmbi.1997.1430", "volume": "275", "author": "M.R. Kho", "year": "1998", "unstructured": "Kho M.R., Baker D.J., Laayoun A., Smith S.S. 1998. Stalling of human DNA (cytosine-5) methyltransferase at single-strand conformers from a site of dynamic mutation. J. Mol. Biol. 275, 67\u201379.", "journal-title": "J. Mol. Biol."}, {"key": "3010_CR18", "doi-asserted-by": "crossref", "first-page": "1182", "DOI": "10.1093/nar/gkl002", "volume": "34", "author": "R. Goyal", "year": "2006", "unstructured": "Goyal R., Reinhardt R., Jeltsch A. 2006. Accuracy of DNA methylation pattern preservation by the Dnmt1 methyltransferase. Nucleic Acids Res. 34, 1182\u20131188.", "journal-title": "Nucleic Acids Res."}, {"key": "3010_CR19", "doi-asserted-by": "crossref", "first-page": "591", "DOI": "10.1016/S0022-2836(02)00676-9", "volume": "321", "author": "L. Zhou", "year": "2002", "unstructured": "Zhou L., Cheng X., Connolly B.A., Dickman M.J., Hurd P.J., Hornby D.P. 2002. Zebularine: A novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases. J. Mol. Biol. 321, 591\u2013599.", "journal-title": "J. Mol. Biol."}, {"key": "3010_CR20", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1006/jmbi.2001.4601", "volume": "308", "author": "C. Liu", "year": "2001", "unstructured": "Liu C., Martin C.T. 2001. Fluorescence characterization of the transcription bubble in elongation complexes of T7 RNA polymerase. J. Mol. Biol. 308, 465\u2013475.", "journal-title": "J. Mol. Biol."}, {"key": "3010_CR21", "doi-asserted-by": "crossref", "first-page": "6305", "DOI": "10.1158/0008-5472.CAN-04-2957", "volume": "65", "author": "B. Brueckner", "year": "2005", "unstructured": "Brueckner B., Boy R.G., Siedlecki P., Musch T., Kliem H.C., Zielenkiewicz P., Suhai S., Wiessler M., Lyko F. 2005. Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Res. 65, 6305\u20136311.", "journal-title": "Cancer Res."}, {"key": "3010_CR22", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1016/0378-1119(88)90253-3", "volume": "74", "author": "Ya.I. Buryanov", "year": "1988", "unstructured": "Buryanov Ya.I., Zinoviev V.V., Gorbunov Yu.A., Tuzikov F.V., Rechkunova N.I., Malygin E.G., Bayev A.A. 1988. Interaction of the EcoDam methyltransferase with synthetic oligodeoxyribonucleotides. Gene. 74, 67\u201369.", "journal-title": "Gene"}, {"key": "3010_CR23", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.2174/1389450003349362", "volume": "1", "author": "M. Szyf", "year": "2000", "unstructured": "Szyf M. 2000. The DNA methylation machinery as a therapeutic target. Curr. Drug Targets. 1, 101\u2013118.", "journal-title": "Curr. Drug Targets."}, {"key": "3010_CR24", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.2147/tcrm.2006.2.4.377", "volume": "2", "author": "K. Raj", "year": "2006", "unstructured": "Raj K., Mufti G.J. 2006. Azacytidine (Vidaza\u00ae) in the treatment of myelodysplastic syndromes. Ther. Clin. Risk Manag. 2, 377\u2013388.", "journal-title": "Ther. Clin. Risk Manag."}, {"key": "3010_CR25", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1517/14656566.8.1.65", "volume": "8", "author": "E. Atallah", "year": "2007", "unstructured": "Atallah E., Kantarjian H., Garcia-Manero G. 2007. The role of decitabine in the treatment of myelodysplastic syndromes. Expert Opin. Pharmacother. 8, 65\u201373.", "journal-title": "Expert Opin. Pharmacother."}, {"key": "3010_CR26", "doi-asserted-by": "crossref", "first-page": "246", "DOI": "10.1196/annals.1359.037", "volume": "1058", "author": "V.E. Marquez", "year": "2005", "unstructured": "Marquez V.E., Kelley J.A., Agbaria R., Ben Kasus T., Cheng J.C., Yoo C.B., Jones P.A. 2005. Zebularine: A unique molecule for an epigenetically based strategy in cancer chemotherapy. Ann. N. Y. Acad. Sci. 1058, 246\u2013254.", "journal-title": "Ann. N. Y. Acad. Sci."}, {"key": "3010_CR27", "doi-asserted-by": "crossref", "first-page": "2794", "DOI": "10.1158/0008-5472.CAN-05-2821", "volume": "66", "author": "C. Stresemann", "year": "2006", "unstructured": "Stresemann C., Brueckner B., Musch T., Stopper H., Lyko F. 2006. Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res. 66, 2794\u20132800.", "journal-title": "Cancer Res"}, {"key": "3010_CR28", "doi-asserted-by": "crossref", "first-page": "24250", "DOI": "10.1074/jbc.274.34.24250", "volume": "274", "author": "M. Fournel", "year": "1999", "unstructured": "Fournel M., Sapieha P., Beaulieu N., Besterman J.M., MacLeod A.R. 1999. Down-regulation of human DNA-(cytosine-5) methyltransferase-induces cell cycle regulators p16ink4A and p21WAF/Cip1 by distinct mechanisms. J. Biol. Chem. 274, 24250\u201324256.", "journal-title": "J. Biol. Chem."}, {"key": "3010_CR29", "doi-asserted-by": "crossref", "first-page": "17986", "DOI": "10.1074/jbc.C900894199", "volume": "275", "author": "J.D. Knox", "year": "2000", "unstructured": "Knox J.D., Araujo F.D., Bigey P., Slack A.D., Price G.B., Zannis-Hadjopoulos M., Szyf M. 2000. Inhibition of DNA methyltransferase inhibits DNA replication. J. Biol. Chem. 275, 17986\u201317990.", "journal-title": "J. Biol. Chem."}, {"key": "3010_CR30", "doi-asserted-by": "crossref", "first-page": "766", "DOI": "10.1093/annonc/mdg216", "volume": "14", "author": "D.J. Stewart", "year": "2003", "unstructured": "Stewart D.J., Donehower R.C., Eisenhauer E.A., Wainman N., Shah A.K., Bonfils C., MacLeod A.R., Besterman J.M., Reid G.K. 2003. A phase I pharmacokinetic and pharmacodynamic study of the DNA methyltransferase 1 inhibitor MG98 administered twice weekly. Ann. Oncol. 14, 766\u2013774.", "journal-title": "Ann. Oncol."}, {"key": "3010_CR31", "doi-asserted-by": "crossref", "first-page": "6353", "DOI": "10.1074/jbc.275.9.6353", "volume": "275", "author": "S. Milutinovic", "year": "2000", "unstructured": "Milutinovic S., Knox J.D., Szyf M. 2000. DNA methyltransferase inhibition induces the transcription of the tumor suppressor p21WAF1/CIP1/sdi1. J. Biol. Chem. 275, 6353\u20136359.", "journal-title": "J. Biol. Chem."}], "container-title": ["Molecular Biology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1134/S0026893309030108.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1134/S0026893309030108/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1134/S0026893309030108", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 3]], "date-time": "2019-06-03T22:33:48Z", "timestamp": 1559601228000}, "score": 23.83518, "issued": {"date-parts": [[2009, 6]]}, "references-count": 31, "journal-issue": {"published-print": {"date-parts": [[2009, 6]]}, "issue": "3"}, "alternative-id": ["3010"], "URL": "http://dx.doi.org/10.1134/s0026893309030108", "relation": {"cites": []}, "ISSN": ["0026-8933", "1608-3245"], "issn-type": [{"value": "0026-8933", "type": "print"}, {"value": "1608-3245", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T04:12:25Z", "timestamp": 1574395945553}, "reference-count": 48, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 1, 1]], "date-time": "2010-01-01T00:00:00Z", "timestamp": 1262304000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Bioorganic & Medicinal Chemistry"], "published-print": {"date-parts": [[2010, 1]]}, "DOI": "10.1016/j.bmc.2009.11.050", "type": "journal-article", "created": {"date-parts": [[2009, 11, 28]], "date-time": "2009-11-28T09:29:21Z", "timestamp": 1259400561000}, "page": "822-829", "source": "Crossref", "is-referenced-by-count": 101, "title": ["Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation"], "prefix": "10.1016", "volume": "18", "author": [{"given": "Dirk", "family": "Kuck", "sequence": "first", "affiliation": []}, {"given": "Narender", "family": "Singh", "sequence": "additional", "affiliation": []}, {"given": "Frank", "family": "Lyko", "sequence": "additional", "affiliation": []}, {"given": "Jose L.", "family": "Medina-Franco", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Bioorganic & Medicinal Chemistry"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0968089609010682?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0968089609010682?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 14]], "date-time": "2018-12-14T23:59:13Z", "timestamp": 1544831953000}, "score": 23.765793, "issued": {"date-parts": [[2010, 1]]}, "references-count": 48, "journal-issue": {"published-print": {"date-parts": [[2010, 1]]}, "issue": "2"}, "alternative-id": ["S0968089609010682"], "URL": "http://dx.doi.org/10.1016/j.bmc.2009.11.050", "ISSN": ["0968-0896"], "issn-type": [{"value": "0968-0896", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T14:25:22Z", "timestamp": 1574864722164}, "reference-count": 161, "publisher": "Elsevier", "isbn-type": [{"value": "9780128095522", "type": "print"}], "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2018, 1, 1]], "date-time": "2018-01-01T00:00:00Z", "timestamp": 1514764800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018]]}, "DOI": "10.1016/b978-0-12-809552-2.00005-x", "type": "book-chapter", "created": {"date-parts": [[2017, 11, 28]], "date-time": "2017-11-28T23:49:12Z", "timestamp": 1511912952000}, "page": "117-140", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Genetic and Epigenetic Modifications in Pancreatic Cancer"], "prefix": "10.1016", "author": [{"given": "Sanjay", "family": "Kumar", "sequence": "first", "affiliation": []}, {"given": "Rajesh", "family": "Singh", "sequence": "additional", "affiliation": []}, {"given": "Manoj K.", "family": "Mishra", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Epigenetic Mechanisms in Cancer"], "link": [{"URL": "https://api.elsevier.com/content/article/PII:B978012809552200005X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:B978012809552200005X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 10, 7]], "date-time": "2019-10-07T01:46:37Z", "timestamp": 1570412797000}, "score": 23.43354, "issued": {"date-parts": [[2018]]}, "ISBN": ["9780128095522"], "references-count": 161, "URL": "http://dx.doi.org/10.1016/b978-0-12-809552-2.00005-x"}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T22:29:19Z", "timestamp": 1575498559216}, "reference-count": 0, "publisher": "Allied Academies", "issue": "01", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["cancer-immunology"], "DOI": "10.35841/cancer-immunology.1.1.4-5", "type": "journal-article", "created": {"date-parts": [[2019, 8, 19]], "date-time": "2019-08-19T10:28:02Z", "timestamp": 1566210482000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Impact of immune checkpoint inhibitors in cancer immunotherapy."], "prefix": "10.35841", "volume": "01", "author": [{"given": "Kota V", "family": "Ramana", "sequence": "first", "affiliation": []}], "member": "21504", "published-online": {"date-parts": [[2018]]}, "container-title": ["Journal of Cancer Immunology & Therapy"], "deposited": {"date-parts": [[2019, 8, 19]], "date-time": "2019-08-19T10:28:05Z", "timestamp": 1566210485000}, "score": 22.784855, "issued": {"date-parts": [[2018]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2018]]}, "issue": "01"}, "URL": "http://dx.doi.org/10.35841/cancer-immunology.1.1.4-5"}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T14:14:00Z", "timestamp": 1574432040494}, "reference-count": 0, "publisher": "Informa UK Limited", "issue": "8", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Biology & Therapy"], "published-print": {"date-parts": [[2008, 8]]}, "DOI": "10.4161/cbt.7.8.6215", "type": "journal-article", "created": {"date-parts": [[2010, 5, 26]], "date-time": "2010-05-26T18:33:20Z", "timestamp": 1274898800000}, "page": "1182-1190", "source": "Crossref", "is-referenced-by-count": 121, "title": ["A novel role for mitochondria in regulating epigenetic modifications in the nucleus"], "prefix": "10.1080", "volume": "7", "author": [{"given": "Dominic", "family": "Smiraglia", "sequence": "first", "affiliation": []}, {"given": "Mariola", "family": "Kulawiec", "sequence": "additional", "affiliation": []}, {"given": "Gaia L.", "family": "Bistulfi", "sequence": "additional", "affiliation": []}, {"given": "Sampa", "family": "Ghoshal", "sequence": "additional", "affiliation": []}, {"given": "Keshav K.", "family": "Singh", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2014, 10, 27]]}, "container-title": ["Cancer Biology & Therapy"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.4161/cbt.7.8.6215", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 12]], "date-time": "2016-12-12T09:59:07Z", "timestamp": 1481536747000}, "score": 22.62742, "issued": {"date-parts": [[2008, 8]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2014, 10, 27]]}, "published-print": {"date-parts": [[2008, 8]]}, "issue": "8"}, "alternative-id": ["10.4161/cbt.7.8.6215"], "URL": "http://dx.doi.org/10.4161/cbt.7.8.6215", "ISSN": ["1538-4047", "1555-8576"], "issn-type": [{"value": "1538-4047", "type": "print"}, {"value": "1555-8576", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T01:54:26Z", "timestamp": 1574733266648}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2015, 7]]}, "DOI": "10.1158/1538-8514.pi3k14-a27", "type": "proceedings-article", "created": {"date-parts": [[2015, 10, 5]], "date-time": "2015-10-05T22:13:55Z", "timestamp": 1444083235000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Abstract A27: Dual PI3K/BRD4 (kinase/epigenetic) inhibitors for maximal MYC control in cancer therapeutics"], "prefix": "10.1158", "author": [{"given": "Alok R.", "family": "Singh", "sequence": "first", "affiliation": []}, {"given": "Shweta", "family": "Joshi", "sequence": "additional", "affiliation": []}, {"given": "Joseph R.", "family": "Garlich", "sequence": "additional", "affiliation": []}, {"given": "Guillermo A.", "family": "Morales", "sequence": "additional", "affiliation": []}, {"given": "Donald Lee", "family": "Durden", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2015, 7, 6]]}, "event": {"name": "Abstracts: AACR Special Conference: Targeting the PI3K-mTOR Network in Cancer; September 14-17, 2014; Philadelphia, PA"}, "container-title": ["PI3K-mTOR Activation in Human Cancer"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-8514.PI3K14-A27", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 9]], "date-time": "2019-05-09T19:40:23Z", "timestamp": 1557430823000}, "score": 22.462524, "issued": {"date-parts": [[2015, 7]]}, "references-count": 0, "alternative-id": ["10.1158/1538-8514.PI3K14-A27"], "URL": "http://dx.doi.org/10.1158/1538-8514.pi3k14-a27"}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T20:55:39Z", "timestamp": 1574283339335}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pancreas"], "published-print": {"date-parts": [[2007, 11]]}, "DOI": "10.1097/01.mpa.0000297762.74831.39", "type": "journal-article", "created": {"date-parts": [[2009, 3, 3]], "date-time": "2009-03-03T23:20:02Z", "timestamp": 1236122402000}, "page": "420-421", "source": "Crossref", "is-referenced-by-count": 0, "title": ["THE EZH2 HISTONE METHYLTRANSFERASE CONTRIBUTES TO PANCREATIC CANCER CELL PROLIFERATION THROUGH EPIGENETIC SILENCING OF CDK INHIBITOR GENES"], "prefix": "10.1097", "volume": "35", "author": [{"given": "A. V.", "family": "Ougolkov", "sequence": "first", "affiliation": []}, {"given": "M. E.", "family": "Fernandez-Zapico", "sequence": "additional", "affiliation": []}, {"given": "D. D.", "family": "Billadeau", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Pancreas"], "language": "en", "link": [{"URL": "http://journals.lww.com/pancreasjournal/Fulltext/10.1097/01.mpa.0000297762.74831.39", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 29]], "date-time": "2018-11-29T14:11:02Z", "timestamp": 1543500662000}, "score": 22.30402, "subtitle": [""], "issued": {"date-parts": [[2007, 11]]}, "references-count": 0, "journal-issue": {"issue": "4"}, "URL": "http://dx.doi.org/10.1097/01.mpa.0000297762.74831.39", "ISSN": ["0885-3177"], "issn-type": [{"value": "0885-3177", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T00:23:47Z", "timestamp": 1574727827472}, "reference-count": 0, "publisher": "InTech", "isbn-type": [{"value": "9789535128250", "type": "print"}, {"value": "9789535128267", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.5772/65905", "type": "book-chapter", "created": {"date-parts": [[2016, 12, 19]], "date-time": "2016-12-19T12:38:05Z", "timestamp": 1482151085000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Changes in DNA Sequence and Methylation Contribute to the Predisposition of Schizophrenia: Toward an Epigenetic Therapy"], "prefix": "10.5772", "author": [{"given": "Melkaye G.", "family": "Melka", "sequence": "first", "affiliation": []}, {"given": "Christina A.", "family": "Castellani", "sequence": "additional", "affiliation": []}, {"given": "Shiva M.", "family": "Singh", "sequence": "additional", "affiliation": []}], "member": "3774", "published-online": {"date-parts": [[2016, 12, 14]]}, "container-title": ["Schizophrenia Treatment - The New Facets"], "link": [{"URL": "http://www.intechopen.com/download/pdf/52966", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 29]], "date-time": "2016-12-29T10:29:34Z", "timestamp": 1483007374000}, "score": 21.563648, "issued": {"date-parts": [[2016, 12, 14]]}, "ISBN": ["9789535128250", "9789535128267"], "references-count": 0, "URL": "http://dx.doi.org/10.5772/65905"}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T15:21:35Z", "timestamp": 1574436095790}, "reference-count": 0, "publisher": "Informa UK Limited", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Biology & Therapy"], "published-print": {"date-parts": [[2007, 4, 10]]}, "DOI": "10.4161/cbt.6.4.4201", "type": "journal-article", "created": {"date-parts": [[2010, 6, 10]], "date-time": "2010-06-10T19:05:55Z", "timestamp": 1276196755000}, "page": "481-486", "source": "Crossref", "is-referenced-by-count": 81, "title": ["MUC1: A target molecule for cancer therapy"], "prefix": "10.1080", "volume": "6", "author": [{"given": "Ravibhushan", "family": "Singh", "sequence": "first", "affiliation": []}, {"given": "Dilip", "family": "Bandyopadhyay", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2014, 10, 27]]}, "container-title": ["Cancer Biology & Therapy"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.4161/cbt.6.4.4201", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 12]], "date-time": "2016-12-12T09:46:08Z", "timestamp": 1481535968000}, "score": 21.192902, "issued": {"date-parts": [[2007, 4, 10]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2014, 10, 27]]}, "published-print": {"date-parts": [[2007, 4, 10]]}, "issue": "4"}, "alternative-id": ["10.4161/cbt.6.4.4201"], "URL": "http://dx.doi.org/10.4161/cbt.6.4.4201", "ISSN": ["1538-4047", "1555-8576"], "issn-type": [{"value": "1538-4047", "type": "print"}, {"value": "1555-8576", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T07:07:12Z", "timestamp": 1574492832950}, "reference-count": 0, "publisher": "Informa UK Limited", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Biology & Therapy"], "published-print": {"date-parts": [[2003, 3]]}, "DOI": "10.4161/cbt.2.2.286", "type": "journal-article", "created": {"date-parts": [[2011, 2, 3]], "date-time": "2011-02-03T21:25:12Z", "timestamp": 1296768312000}, "page": "137-140", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Why Iressa Failed: Toward a Novel Use of Kinase Inhibitors"], "prefix": "10.1080", "volume": "2", "author": [{"given": "Mikhail V.", "family": "Blagosklonny", "sequence": "first", "affiliation": []}, {"given": "Zbigniew", "family": "Darzynkiewicz", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2014, 10, 28]]}, "container-title": ["Cancer Biology & Therapy"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.4161/cbt.2.2.286", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 12]], "date-time": "2016-12-12T09:03:35Z", "timestamp": 1481533415000}, "score": 21.162525, "issued": {"date-parts": [[2003, 3]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2014, 10, 28]]}, "published-print": {"date-parts": [[2003, 3]]}, "issue": "2"}, "alternative-id": ["10.4161/cbt.2.2.286"], "URL": "http://dx.doi.org/10.4161/cbt.2.2.286", "ISSN": ["1538-4047", "1555-8576"], "issn-type": [{"value": "1538-4047", "type": "print"}, {"value": "1555-8576", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T04:52:27Z", "timestamp": 1574484747077}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2011, 4, 15]]}, "DOI": "10.1158/1538-7445.am2011-3599", "type": "proceedings-article", "created": {"date-parts": [[2012, 6, 27]], "date-time": "2012-06-27T21:11:40Z", "timestamp": 1340831500000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract 3599: Aurora kinase inhibitors as a novel targeted drug therapy for bladder cancer"], "prefix": "10.1158", "author": [{"given": "Ning", "family": "Zhou", "sequence": "first", "affiliation": []}, {"given": "Kamini", "family": "Singh", "sequence": "additional", "affiliation": []}, {"given": "Alexandru", "family": "Almasan", "sequence": "additional", "affiliation": []}, {"given": "Donna", "family": "Hansel", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 13]]}, "event": {"name": "Proceedings: AACR 102nd Annual Meeting 2011\u2010\u2010 Apr 2\u20106, 2011; Orlando, FL"}, "container-title": ["Experimental and Molecular Therapeutics"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2011-3599", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T21:49:31Z", "timestamp": 1558216171000}, "score": 21.022667, "issued": {"date-parts": [[2011, 4, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2011-3599"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2011-3599"}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}